Merrick I. Ross, Charles M. McBride Distinguished Professor

Local Presentations

1. 2025. Surgical Management of Merkel Cell Carcinoma: Advances and Opportunities in Systemic Therapy for MCC. Conference. 2025 Art and Science of Managing the New Melanoma Landscape. Houston, Texas, US.
2. 2025. The Multidisciplinary Management of Stage III Melanoma. Conference. 2025 Art and Science of Managing the New Melanoma Landscape. Houston, Texas, US.
3. 2025. Surgery for Clinically Localized Disease - What's New?. Conference. 2025 Art and Science of Managing the New Melanoma Landscape. Houston, Texas, US.
4. 2020. 2020 Art and Science of Managing the New Melanoma Landscape. Conference. MD Anderson Cancer Center. Houston, TX, US.
5. 2019. MDACC Cancer Network Symposium. Conference. MD Anderson Cancer Center. Houston, TX, US.
6. 2019. 2019 Art and Science of Managing the New Melanoma Landscape Conference. Conference. MD Anderson Cancer Center. Houston, TX, US.
7. 2019. Surgical Management of Clinically Localized Disease. Conference. The University of Texas MD Anderson Cancer Center, Department of Surgical and Medical Melanoma. Houston, TX, US.
8. 2019. GAP Melanoma Session. Conference. GAP. Houston, TX, US.
9. 2018. Surgical Management of Clinically Localized Disease. Conference. The University of Texas MD Anderson Cancer Center, Department of Surgical and Medical Melanoma. Houston, TX, US.
10. 2014. Surgery for Distant Metastatic Disease. Conference. Prova Education. Houston, TX, US.
11. 2014. Novel Strategies for Regional Disease. Conference. Prova Education. Houston, TX, US.
12. 2013. Melanoma/Skin Surgery. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
13. 2013. Surgical Advances in the Treatment of Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
14. 2013. Surgery for Distant Metastatic Disease. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
15. 2013. Surgery for Distant Metastatic Disease. Conference. US Health Connect. Houston, TX, US.
16. 2013. The Role of Neoadjuvant Therapy. Conference. US Health Connect. Houston, TX, US.
17. 2013. The Role of Neoadjuvant Therapy for Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
18. 2012. Modern Management of Resectable Melanoma: Strategies for Clinical Decision-Making. Conference. Prime Oncology Inc. Houston, TX, US.
19. 2012. I've Been Diagnosed with Melanoma...Where Do I Go From Here?. Conference. Melanoma Research Foundation. Houston, TX, US.
20. 2010. A New Era of Assessing and Managing Risk of Recurrence for Breast Cancer Patients. Conference. Genomic Health. Houston, TX, US.
21. 2007. Surgery. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
22. 2007. Does Sentinel Lymph Node Biopsy Increase Survival. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
23. 2002. The Utility of Sentinel Node Assessment in Early-Stage Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
24. 2001. Ask the Experts About Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
25. 2001. Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
26. 2001. Surgical Advances in the Treatment of Malignant Melanoma. Conference. Melanoma Research Foundation. Houston, TX, US.
27. 2001. Update on Sentinel Node Biopsy in Melanoma and Breast Cancer Patients. Conference. Houston Surgical Society. Houston, TX, US.
28. 1997. Lymphatic Mapping and Sentinel Node Biopsy for Breast and Melanoma. Conference. Texas Society of Gulf Coast Dermatology Nurses. Houston, TX, US.
29. 1996. The Evolution of Lymphatic Mapping and Sentinel Node Dissection in the Management of Early Stage Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
30. 1996. Melanoma. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
31. 1996. Review of Active Sarcoma Protocols. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
32. 1996. Sentinel Node Biopsy - An Alternative to Axillary Node Dissection. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
33. 1996. Role of Axillary Node Mapping. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
34. 1995. Melanoma. Conference. St. Lukes Hospital Continuing Medical Education Program. Houston, TX, US.
35. 1993. Management of Early Stage Melanoma. Conference. Texas Medical Association. Houston, TX, US.
36. 1991. Surgical Therapy for Stage I and II Breast Cancer. Conference. Cancer Update. Houston, TX, US.
37. 1991. Mucosal Melanoma. Conference. 35th Annual Clinical Conference on Melanoma. Houston, TX, US.

Regional Presentations

1. 2024. Melanoma Updates from the Surgical Oncology Perspective. Conference. 76th Pacific Dermatology Conference 2024. Huntington Beach, CA, US.
2. 2024. Multidisciplinary Approach to Cancers. Conference. St. Luke's Anderson Campus. Kauhi, HI, US.
3. 2024. A Fresh Look at Oncolytic Immunotherapy. Conference. Scripps Clinic. San Diego, CA, US.
4. 2024. Neoadjuvant Breakthroughs in Advanced Resectable Melanoma. Conference. Scripps Clinic. San Diego, CA, US.
5. 2024. Insights into Sentinel Node Evaluation: 2024 Update. Conference. Scripps Clinic. San Diego, CA, US.
6. 2023. Breast Cancer Updates 2024. Conference. Indochina Curie Institute - Vietnam. Hanoi, VN.
7. 2021. MDS VIRTUAL GLOBAL MELANOMA AD BOARD. Conference. MDS. Virtual Meeting, US.
8. 2021. MSD Global Melanoma Advisory Board Meeting. Conference. MSD. Virtual Meeting, US.
9. 2021. Global Melanoma Ad Board Team Meeting. Conference. Merck. Virtual Meeting, US.
10. 2021. Melanoma Clinical Immersion Program. Conference. Merck. Virtual, US.
11. 2021. Melanoma Clinical Immersion Program. Conference. Merck. Virtual Meeting, US.
12. 2020. NCCN Cutaneous Melanoma Surgery Subcommittee Meeting. Conference. NCCN. Virtual, US.
13. 2020. NCCN Cutaneous Melanoma Surgery Subcommittee Meeting. Conference. NCCN. Virtual, US.
14. 2019. Global Melanoma Advisory Board. Conference. MSD. Hoboken, NJ, US.
15. 2019. Surgical Management for Metastatic Melanoma. Conference. Banner MD Anderson Cancer Center - TW Lewis Melanoma Center of Excellence Symposium. Scottsdale, AZ, US.
16. 2018. Future Melanoma Treatment Landscape. Conference. Merck. Dublin, IE.
17. 2018. Future Melanoma Treatment Landscape. Conference. Amgen. Dallas, TX, US.
18. 2018. Qessential Medical Ad Board. Conference. Qessential. Chicago, IL, US.
19. 2017. Sentinal Nodes for Melanoma. Conference. Dr. Hugh Greenway's 34th Annual Superficial Anatomy and Cutaneous Surgery. San Diego, CA, US.
20. 2015. Surgical techniques and role of adjunct therapy in melanoma. Conference. 1st Annual West Cancer Center Oncology Conference. Memphis, TN, US.
21. 2014. Novel Treatment Approaches to Melanoma In-Transit Metastasis. Conference. The University of Texas MD Anderson Cancer Center. Boston, MA, US.
22. 2014. Advances in Adjuvant Therapy with Ipilimumab. Conference. DAVA Oncology. Palm Beach, FL, US.
23. 2014. Mechanisms and Patterns of Response with Oncolytic Therapy. Conference. Dava Oncology. Palm Beach, FL, US.
24. 2014. Sentinel Nodes for Melanoma. Conference. UC San Diego School of Medicine. San Diego, CA, US.
25. 2014. Surgical Approach to Locally Advanced Melanoma. Conference. DAVA Oncology. Dallas, TX, US.
26. 2014. New Approaches to Limb Perfusion Therapy. Conference. DAVA Oncology. Dallas, TX, US.
27. 2014. Gene Expression Profiling as a Predictor for Early-Stage Disease. Conference. DAVA Oncology. Dallas, TX, US.
28. 2013. Adjuvant Therapy for High-Risk Melanoma: Current Standards and Future Directions. Conference. The University of Texas MD Anderson Cancer Center. Orlando, FL, US.
29. 2013. Management of Intralesional Therapy for Unresectable Metastatic Melanoma. Conference. Paradigm Medical Communications, LLC. Chicago, IL, US.
30. 2012. Modern Management of Resectable Melanoma: Strategies for Clinical Decision-Making. Conference. Prime Oncology Inc. Atlanta, GA, US.
31. 2012. Modern Management of Resectable Melanoma: Strategies for Clinical Decision-Making. Conference. Prime Oncology Inc. Los Angeles, CO, US.
32. 2012. PV-10 as an Adjuvant Therapy for the Treatment of Malignant Melanoma. Conference. The Mary Crowely Cancer Research Center. Dallas, TX, US.
33. 2011. Melanoma Update. Conference. California Dermatologic Surgery Society. San Diego, CA, US.
34. 2011. The Surgical Approach to Soft Tissue Tumors. Conference. American Society for Mohs Surgery. Orlando, FL, US.
35. 2011. Melanoma Update 2011 - Evaluation and Treatment by Stage. Conference. Oklahoma State Dermatological Society. Tulsa, OK, US.
36. 2010. Melanoma Landscape. Conference. DAVA Oncology. Dallas, TX, US.
37. 2010. Melanoma Landscape. Conference. DAVA Oncology. Los Angeles, CA, US.
38. 2010. Melanoma Update - Sentinel Node Biopsy Consideration. Conference. DAVA Oncology. W. Palm Beach, FL, US.
39. 2010. Melanoma Landscape. Conference. DAVA Oncology. West Palm Beach, FL, US.
40. 2010. Melanoma Landscape. Conference. DAVA Oncology. Miami, FL, US.
41. 2010. Melanoma Landscape. Conference. DAVA Oncology. Dallas, TX, US.
42. 2009. Melanoma update: Treatment in a referral center. Conference. American Society for Mohs Surgery. Horseshoe Bay, TX, US.
43. 2009. Our Current Understanding of the Treatment of Melanoma. Conference. American Society of Plastic Surgery. San Diego, CO, US.
44. 2007. Surgical Advances in Treating Melanoma. Conference. Adelson Medical Research Foundation. Las Vegas, NV, US.
45. 2007. Sentinel Node Evaluation. Conference. Scripps Clinic. San Diego, CA, US.
46. 2005. Surgical Advances in the Treatment of Malignant Melanoma. Conference. Dallas Society of General Surgeons. Dallas, TX, US.
47. 2001. Lymphatic Mapping and Sentinel Node Biopsy for Malignant Melanoma. Conference. Texas Hematology/Oncology Center, Trinity Medical Center. Carrolton, TX, US.
48. 2001. Sarcoma – When to Get Aggressive. Conference. Orange County Surgical Society. Newport Beach, CA, US.
49. 2001. Sentinel Node Biopsy for Breast Cancer. Conference. Orange County Surgical Society. Newport Beach, CA, US.
50. 2001. Sentinel Lymph Node Biopsy for Melanoma. Conference. Orange County Surgical Society. Newport Beach, CA, US.
51. 2000. Breast Cancer. Conference. Macarthur Surgical Clinic. Alexandria, LA, US.
52. 1999. ACOSOG Melanoma Subcommittee Update. Conference. Eastern Cooperative Oncology Group. Tampa, FL, US.
53. 1999. Study Coordinator's Workshop. Conference. American College of Surgeons Oncology Group. Rosemont, IL, US.
54. 1999. Lymphatic Mapping for Breast Cancer. Conference. Miami Breast Cancer Conference. Miami Beach, FL, US.
55. 1998. Sentinel Lymph Node Biopsy for Breast Cancer. Conference. Michicana Breast Cancer Symposium. South Bend, IN, US.
56. 1997. Surgical Options for Early Stage Breast Cancer. Conference. Valley Baptist Medical Center. Harlingen, TX, US.
57. 1997. Sunbelt Melanoma Trial. Conference. James G. Brown Cancer Center. Louisville, KY, US.
58. 1997. The Current Therapy of Malignant Melanoma. Conference. South Texas Chapter of the American College of Surgeons. San Antonio, TX, US.
59. 1996. Update on Recent FDA Approval for Adjuvant Treatment of Melanoma and Overview of ECOG #1684. Conference. Texas Society of Plastic Surgeons. San Antonio, TX, US.
60. 1996. Breast Cancer Prevention and Treatment. Conference. San Francisco Hassadah Society. San Francisco, CA, US.
61. 1996. Staging and Treatment of Melanoma. Conference. Oklahoma State Dermatological Society. McAlester, OK, US.
62. 1996. Update and Treatment of Melanoma: ECOG #1684. Conference. San Antonio Surgical Society. San Antonio, TX, US.
63. 1995. The Advances of Melanoma: The Anderson Experience. Conference. Baptist Hospital. Beaumont, TX, US.

National Presentations

1. 2025. The Neoadjuvant Revolution. Invited. PRIMO 2025-Practical Recommendations in Immune & Molecular Oncology. Honolulu, Hawaii, US.
2. 2025. A Fresh Look at Oncolytic Immunotherapy. Invited. Melanoma and Cutaneous Oncology Symposium 2025. Coronado, California, US.
3. 2025. Sentinel Lymph Node Imaging for Squamous Cell Carcinoma and Non-Melanoma Skin Cancer. Invited. Melanoma and Cutaneous Oncology Symposium 2025. Coronado, California, US.
4. 2025. Insights Into Sentinel Node Evaluation: 2024 Update. Invited. Melanoma and Cutaneous Oncology Symposium 2025. Coronado, California, US.
5. 2021. 11th European Post‐Chicago Melanoma/Skin Cancer Meeting. Invited. 11th European Post‐Chicago Melanoma/Skin Cancer Meeting. Virtual Meeting, US.
6. 2021. Scripps Annual Cutaneous Malignancies Conference. Conference. Scripps. Virtual Meeting, US.
7. 2020. The Cutaneous Malignancies Forum. Invited. The Cutaneous Malignancies Forum. Virtual Meeting, US.
8. 2020. Virtual Scientific Symposium Sponsored by MSD titled: Redefining Survival. Conference. Merck. Virtual, US.
9. 2020. MERCK – US Global Advisory Board Mtg. Invited. Merck. Virtual, US.
10. 2020. Melanoma 2020: 30th Annual Cutaneous Malignancy Update. Invited. Melanoma 2020: 30th Annual Cutaneous Malignancy Update. San Diego, CA, US.
11. 2019. Society for Melanoma Research. Conference. Society for Melanoma Research. Salt Lake City, UT, US.
12. 2019. 8th Edition of the AJCC Melanoma Staging System. Invited. The Cutaneous Malignancies Forum Contemporary Issues in Effective Diagnosis and Treatment. Las Vegas, NV, US.
13. 2019. Managing Challenging Non-Melanoma Tumors - Panel Discussion. Invited. 24th Annual Meeting for Dermatologic Surgery: Focus on Skin Cancer. Naples, FL, US.
14. 2019. Stategies for Advanced Lesional Metastasis. Invited. 24th Annual Meeting for Dermatologic Surgery: Focus on Skin Cancer. Naples, FL, US.
15. 2019. Derm Surgery: Focus on Skin Cancer. Invited. Annual ASMS. Naples, FL, US.
16. 2019. Metastatic Melanoma BRAF Wild-Type Disease. Invited. Hem/Onc Today New York 2019. New York, NY, US.
17. 2019. Patient with One Positive Sentinel Lymph Node on Staging. Invited. Hem/Onc Today New York 2019. New York, NY, US.
18. 2019. Hem/Onc Toady. Conference. Hem/Onc Toady. New York, NY, US.
19. 2019. 2nd Annual Melanoma Symposium. Conference. 2nd Annual Melanoma Symposium. Scotsdale, AZ, US.
20. 2019. NRG Oncology – 2019. Conference. NRG Oncology – 2019. Pheonix, AZ, US.
21. 2019. Oncolytic Immunotherapy. Invited. 29th Annual Cutaneous Malignancy Update. San Diego, CA, US.
22. 2019. Neoadjuvant Therapy for Advanced Resectable Melanoma. Invited. 29th Annual Cutaneous Malignancy Update. San Diego, CA, US.
23. 2019. Sentinel Node Evaluation. Invited. 29th Annual Cutaneous Malignancy Update. San Diego, CA, US.
24. 2019. 29th Annual Cutaneous Malignancy Update. Invited. 29th Annual Cutaneous Malignancy Update. San Diego, CA, US.
25. 2019. Metastatic Melanoma BRAF-Positive Disease. Invited. Hem/Onc Today New York 2019. New York, NY, US.
26. 2018. Merck Global Ad Board Meeting. Conference. Merck Global Ad Board Meeting, US.
27. 2018. Melanoma: Treatment and Surgical Reconstruction. Invited. American Society of Plastic Surgeons. Chicago, IL, US.
28. 2018. Sentinal Nodes for Melanoma. Invited. Scripps Clinic and University of California, San Diego. San Diego, CA, US.
29. 2018. 35th Annual Superficial Anatomy and Cutaneous Surgery. Invited. Scripps Clinic. San Diego, CO, US.
30. 2018. Managing Challenging Non-Melanoma Tumors: Panel Discussion. Invited. 23rd Annual Meeting Dermatologic Surgery: Focus on Skin Cancer. Orlando, FL, US.
31. 2018. Managing Challenging Non-Melanoma Tumors: Panel Discussion. Invited. 23rd Annual Meeting Dermatologic Surgery: Focus on Skin Cancer. Orlando, FL, US.
32. 2018. Controversies in Skin Cancer Treatment. Invited. 23rd Annual Meeting Dermatologic Surgery: Focus on Skin Cancer. Orlando, FL, US.
33. 2018. Interactive Melanoma Panel Case Studies. Invited. 23rd Annual Meeting Dermatologic Surgery: Focus on Skin Cancer. Orlando, FL, US.
34. 2018. New AJCC Staging Criteria & Evidence Basis for Their Changes. Invited. 23rd Annual Meeting Dermatologic Surgery: Focus on Skin Cancer. Orlando, FL, US.
35. 2018. What are the implications for practice?. Invited. Merck. Chicago, IL, US.
36. 2018. 71st Society of Surgical Oncology Annual Symposium 2018 Meeting. Invited. Current Management of Nodal Metastases in Patients with Melanoma. Chicago, IL, US.
37. 2018. Case Studies: Melanoma and Genitourinary Cancer. Invited. HemOnctoday New York 2018 Program. New York, NY, US.
38. 2018. Completion Dissection in Patients with a Positive Sentinel Node: Is the controversy finally resolved?. Invited. 16th Oncology Update: Advances and Controversies. Steamboart, CO, US.
39. 2018. Neo-adjuvant approaches to resectable advanced disease: Is this a new paradigm?. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
40. 2017. Current Clinical Controversies and Conundrums in Melanoma Management. Invited. 36th Annual Meeting Florida Society of Dermatologic Surgeons. Orlando, FL, US.
41. 2017. Appropriate Imaging Studies in Skin Cancer Workup. Invited. 36th Annual Meeting Florida Society of Dermatologic Surgeons. Orlando, FL, US.
42. 2017. Managing Challenging Non-Melanoma Tumors: A Panel Presentation and Discussion. Invited. American Society for MOHS Surgery. Miramar Beach, FL, US.
43. 2017. Interactive Melanoma Panel Cases Studies. Invited. American Society for MOHS Surgery. Miramar Beach, FL, US.
44. 2017. Appropriate Imaging Studies in Skin Cancer Workups. Invited. American Society for MOHS Surgery. Miramar Beach, FL, US.
45. 2017. Controversies in Melanoma Treatment: Completion Lymph Node Dissection, Gene Expression, Sentinel Node Biopsy. Invited. American Society for MOHS Surgery. Miramar Beach, FL, US.
46. 2017. Surgical Treatment of Melanoma. Invited. MRF Patient Symposium. Austin, TX, US.
47. 2017. How to Integrate Intralesional Therapy in Clinical Practice. Invited. HemOnc today Melanoma and Cutaneous Malignancies 2017 Meeting. New York, NY, US.
48. 2017. Oncolytic Immunotherapy. Invited. Scripps Clinic, Surgery. Coronado, CA, US.
49. 2017. Neoadjuvant Therapy for Advanced Resectable Melanoma. Invited. Scripps Clinic, Surgery. Coronado, CO, US.
50. 2017. Sentinel Node Evaluation. Invited. Scripps Clinic, Surgery. Coronado, CA, US.
51. 2015. What's a Clinician to Do? Case-Based Roundtable On Advanced Melanoma. Invited. Vindico Medical Education. New York, NY, US.
52. 2015. Is Completion Lymphadenectomy for Sentinel Node Positive Disease Obsolete. Invited. Vindico Medical Education. New York, NY, US.
53. 2014. Recent Advances in Melanoma Management. Invited. American Society for Mohs Surgery. Santa Ana Pueblo, NM, US.
54. 2014. Desmoplastic melanoma: Conundrum of the Year. Invited. Vindico Medical Education. New York, NY, US.
55. 2014. Quality of Life Assessment in Treating Patients with Melanoma. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
56. 2014. Current Status of Adjuvant Therapy: Any Changes on the Horizon?. Conference. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
57. 2013. Metastasectomy for Melanoma: What Is The Role?. Invited. American College of Surgeons. Washington, DC, US.
58. 2013. Contemporary Treatment of Melanoma. Invited. American College of Surgeons. Washington, DC, US.
59. 2013. Surgery, Isolated Limb Perfusion, Injectable Therapy or Systemic Therapy for In-Transit Melanoma. Invited. Perspectives in Melanoma XVII. Baltimore, MD, US.
60. 2013. Surgery, Isolated Limb Perfusion, Injectable Therapy or Systemic Therapy for In-Transit Melanoma. Invited. IMEDEX, Inc. Baltimore, MD, US.
61. 2013. Interactive Melanoma Panel Discussion. Invited. American Society for Mohs Surgery. Amelia Island, FL, US.
62. 2013. Case studies from MD Anderson: High risk and advanced melanomas. Invited. American Society for Mohs Surgery. Amelia Island, FL, US.
63. 2013. Contemporary Tumor Ablative Therapy: What Is Its Role?. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
64. 2013. Surgery for stage IV disease: When and who?. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
65. 2013. Update on Tumor Derived Gene Profiling for Adjuvant Therapy - Breast, Oncotype and Others. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
66. 2013. Adjuvant Therapy for High-Risk Melanoma: Current Standards and Future Directions. Invited. The University of Texas MD Anderson Cancer Center. Steamboat Springs, CO, US.
67. 2012. Evolving Paradigms in the Surgical Management of Distant Melanoma Metastases. Invited. The University of Texas MD Anderson Cancer Center. Chicago, IL, US.
68. 2012. Management of the Axilla in Early-Stage Breast Cancer: Is axillary dissection a procedure of the past?. Invited. 10th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
69. 2012. Adjuvant Therapy for Melanoma: Standard of Care in Evolution. Invited. 10th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
70. 2012. Node Negative and Node Positive Breast Cancer. Invited. 10th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
71. 2011. Importance of Sentinel Lymph Node Biopsy. Invited. Duke University School of Medicine and Cine'-Med. Amelia Island, FL, US.
72. 2011. Intralesional Injection Therapy. Invited. 5th Meeting of Interdisciplinary Melanoma Cancer Centres. Tampa, FL, US.
73. 2011. Sentinel Nodes for Melanoma. Invited. Scripps Clinic. San Diego, CA, US.
74. 2011. Intralesional Therapy for Systemic Disease: Implications for Success and Failure. Invited. HemOncToday and Cutaneous Malignancies. New York, NY, US.
75. 2010. Antigen-Specific Cancer Immunotherapy (ASCI) from Phase II to Phase III. Invited. GlaskoSmithKline/DERMA. Portland, OR, US.
76. 2010. Staging and Prognostic Markers in Melanoma. Invited. University of Tennessee. Memphis, TN, US.
77. 2010. Management of Early Stage Melanoma - Does One Size Fit All?. Invited. The University of Texas MD Anderson Cancer Center. New York, NY, US.
78. 2010. New Melanoma Staging Criteria. Invited. American Society for Mohs Surgery. Monterey, CA, US.
79. 2009. Role of Prophylactic Mastectomy: Why, Who, and How. Invited. 9th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
80. 2009. Update on Management of Advanced Regional Disease. Conference. 9th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
81. 2008. Surgery for Stage IV Disease. Invited. 8th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
82. 2007. Lymphatic Mapping and the Significance of Sentinel Node Biopsy. Invited. American College of Surgeons 93rd Annual Clinical Congress. New Orleans, LA, US.
83. 2007. Advances in Melanoma Stage. Invited. 71st Annual Course, Advances in Breast, Endocrine, and Cancer Surgery. Minneapolis, MN, US.
84. 2007. What Surgeons Should Know About Adjuvant Systemic Therapy. Invited. 71st Annual Course, Advances in Breast, Endocrine and Cancer Surgery. Minneapolis, MN, US.
85. 2007. Controversies in Sentinel Node Evaluation for Melanoma. Invited. American Society for MOHS Surgery. Santa Ana Pueblo, NM, US.
86. 2007. Management of Skin Neoplasms for the General Surgeon. Invited. American College of Surgeons 35th Annual Spring Meeting. Las Vegas, NV, US.
87. 2007. Sentinel Node Biopsy: The Controversy Remains. Invited. 5th Biannual Miami Melanoma Meeting. Miami Beach, FL, US.
88. 2007. Melanoma Therapy: The Dermatologist as Clinician, Surgeon, and Referring Physician. Invited. 31st Annual Hawaii Dermatology Seminar. Wailea, Maui, HI, US.
89. 2007. Special Problems in Melanoma: Management of In-Transit Disease. Invited. 7th Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
90. 2006. Managing Intermediate Thickness Melanoma: Biopsy, Staging, and Therapeutic Recommendations. Invited. The Three R's of Melanoma: Risk, Relapse, and Response Symposium. Chicago, IL, US.
91. 2006. Approaches to the Positive Sentinel Lymph Node and Locoregional Recurrence. Invited. The Three R's of Melanoma: Risk, Relapse, & Response Symposium. Chicago, IL, US.
92. 2006. Lymphatic Mapping and the Significance of Sentinel Node Biopsy. Invited. 92nd Annual Clinical Congress - American College of Surgeons. Chicago, IL, US.
93. 2006. Management of Breast mass in the Premenopausal Patient. Invited. 6th Annual Obstetrics and Gynecology Symposium. El Paso, TX, US.
94. 2006. Melanoma Management: More Than Skin Deep. Invited. Melanoma Care Coalition 2006 Regional Symposium. San Antonio, TX, US.
95. 2006. Sentinel Node Biopsy: The Standard of Care. Invited. Melanoma: An Update on Diagnosis and Treatment Conference. Houston, TX, US.
96. 2006. Should a Complete Lymph Node Dissection Be Performed After Positive Sentinel Lymph Node Biopsy? Pro versus Con. Invited. Melanoma: An Update on Diagnosis and Treatment Conference. Houston, TX, US.
97. 2006. Trends in the Treatment of Melanoma. Invited. 11th Annual NCCN Conference: Clinical Practice Guidelines in Oncology and Quality Cancer Care. Hollywood, FL, US.
98. 2006. Adjuvant Chemotherapy for Breast Cancer: What the Surgeon Should Know. Invited. Southeastern Surgical Congress – Annual Scientific Meeting. Lake Buena Vista, FL, US.
99. 2006. The Sentinel Lymph Node Biopsy – When and How. Invited. 30th Hawaii Dermatology Seminar. Kauai, HI, US.
100. 2006. Melanoma Staging Committee Meeting. Invited. American Joint Committee on Cancer (AJCC). San Francisco, CA, US.
101. 2006. Advances in the Understanding and Treatment of Melanoma. Invited. 2006 Keystone Symposium. Santa Fe, NM, US.
102. 2006. Future Approaches to Melanoma Staging. Invited. 2006 Keystone Symposium. Santa Fe, NM, US.
103. 2006. Sentinel Node Evaluation. Invited. 16th Annual Cutaneous Malignancy Update. San Diego, CA, US.
104. 2006. Special Problems in Melanoma: Management of In-Transit Disease. Invited. 6th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
105. 2006. Core Curriculum Development. Invited. Melanoma Care Consortium 2006. Orangeburg, NJ, US.
106. 2005. Treatment of Melanoma: Surgery and Immunotherapy. Invited. 91st Annual Clinical Congress – American College of Surgeons. San Francisco, CA, US.
107. 2005. Lymphatic Mapping and the Significance of Sentinel Node Biopsy. Invited. 91st Annual Clinical Congress – American College of Surgeons. San Francisco, CA, US.
108. 2005. Evidence-Based Decisions in Cancer Management. Invited. 91st Annual Clinical Congress – American College of Surgeons. San Francisco, CA, US.
109. 2005. Staging/Risk Factors/Regional Therapy. Invited. Innovations and Challenges in Melanoma. Cambridge, MA, US.
110. 2005. Perfusional Approaches to Regional Disease and Surgical Treatment of Metastatic Disease. Invited. 4th Biannual Miami Melanoma Meeting. Miami Beach, FL, US.
111. 2005. Diagnosis Strategies and Treatment of Melanoma. Invited. Melanoma Care Consortium. Houston, TX, US.
112. 2005. Melanoma Case Studies. Invited. 10th Annual Clinical Symposium: Dermatologic Surgery: Focus on Skin Cancer. Phoenix, AZ, US.
113. 2005. The Sunbelt Melanoma Trial and Current Treatment of Melanoma. Invited. Melanoma in the New Millennium: Current Trends & Future Directions St. Francis Cancer Symposium 2005. Greenville, SC, US.
114. 2005. Prognostic Markers from Sentinel Lymph Node Research. Invited. Melanoma US Advisory Board Meeting. Chicago, IL, US.
115. 2005. Advanced Melanoma – Case Studies. Invited. Oklahoma State University Dermatological Society Annual Meeting. Tulsa, OK, US.
116. 2005. Protocol Response of In-Transit Melanoma to System Treatment with the Specific Active Immunotherapeutic Agent Canvaxin. Invited. Canvaxin Protocol Update. Dallas, TX, US.
117. 2005. Early Detection of Skin Cancer. Invited. American College of Surgeon’s Commission on Cancer. Houston, TX, US.
118. 2005. The Sentinel Lymph Node Biopsy. Invited. 29th Hawaiian Dermatology Seminar. Wailea, HI, US.
119. 2005. Canvaxin Overview. Invited. Melanoma Management Dynamics and Canvaxin Protocol Meeting. New York, NY, US.
120. 2005. Update on Malignant Melanoma. Conference. 63rd Annual Meeting of the American Academy of Dermatology. New Orleans, LA, US.
121. 2005. Sentinel Node Biopsy – Current Status and Recommendations. Conference. 63rd Annual Meeting of the American Academy of Dermatology. New Orleans, LA, US.
122. 2005. Melanoma: Update on Diagnosis & Treatment. Conference. Melanoma CME Symposium. Houston, TX, US.
123. 2005. Molecular Targeting in Breast Cancer: The Evolution of HER2. Conference. Crestwood Medical Center Grand Rounds. Huntsville, AL, US.
124. 2005. Sentinel Node Evaluation. Conference. 15th Annual Melanoma 2005: Cutaneous Malignancy Update. San Diego, CA, US.
125. 2005. Special Problems in Melanoma: Management of In-Transit Disease. Conference. 5th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
126. 2005. Sentinel Node of the Head & Neck. Conference. 15th Annual Melanoma 2005: Cutaneous Malignancy Update. San Diego, CA, US.
127. 2004. Title not provided. Conference. Melanoma Care Consortium Webconference. Chicago, IL, US.
128. 2004. Patient with Distant Metastases: Surgical Options. Invited. American College of Surgeons 90th Annual Clinical Congress. New Orleans, LA, US.
129. 2004. Patient with Micrometastatic Melanoma: Pathologic Analysis. Invited. American College of Surgeons 90th Annual Clinical Congress. New Orleans, LA, US.
130. 2004. Early Melanoma Patient: Sentinel Lymph Node Biopsy. Invited. American College of Surgeons 90th Annual Clinical Congress. New Orleans, LA, US.
131. 2004. Early Melanoma Patient: Excisional Therapy. Invited. American College of Surgeons 90th Annual Clinical Congress. New Orleans, LA, US.
132. 2004. Controversies in Sentinel Node Biopsy in Breast Cancer and Melanoma. Invited. American College of Surgeons 90th Annual Clinical Congress. New Orleans, LA, US.
133. 2004. Sentinel Node Biopsy in the Treatment of Melanoma Patient’s. Invited. 4th Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
134. 2004. Malignant Melanoma and Breast Cancer Update. Invited. American College of Surgeons Oncology Group Semiannual Meeting. Miami Beach, FL, US.
135. 2003. Surgery for Stage IV Disease. Invited. 3rd Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
136. 2002. Surgical Advances in the Treatment of Malignant Melanoma. Invited. Oncology Conference. Las Vegas, NV, US.
137. 2002. CancerVax Update. Invited. Clinical Protocols Investigator’s Meeting. La Jolla, CA, US.
138. 2002. Sentinel Node Evaluation. Invited. Melanoma 2002 12th Annual Cutaneous Malignancy Update Conference. La Jolla, CA, US.
139. 2002. Radiofrequency Ablation for Breast Cancer. Invited. 2nd Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
140. 2002. The Role for Vaccine Therapy. Invited. 2nd Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
141. 2001. Sentinel Lymph Node Staging for Melanoma – An Update. Invited. 2nd Symposium on Advances in the Biology and Treatment of Cutaneous Melanoma. Boston, MA, US.
142. 2001. Surgical Advances in the Treatment of Malignant Melanoma. Invited. American Society for Mohs Surgery 6th Annual Clinical Symposium – Dermatologic Surgery for the 21st Century. Newport Beach, CA, US.
143. 2001. CancerVax Update. Invited. Clinical Protocols Investigator’s Meeting. Los Angeles, CA, US.
144. 2001. Randomized Surgical Trials in Melanoma – Past and Future. Invited. Oncology Nursing Society Meeting. Houston, TX, US.
145. 2001. Sentinel Node Biopsy for Breast Cancer – Standard of Care. Invited. 14th Annual Breast Cancer Symposium. Aurora, IL, US.
146. 2001. Surgical Staging of Melanoma. Invited. 4th Foundations of Clinical Cancer Research Symposium. Houston, TX, US.
147. 2001. Sentinel Lymph Node Biopsy in Melanoma – Where are we now. Invited. 1st Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
148. 2001. Skin-Sparing Mastectomy. Invited. 1st Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
149. 2001. Randomized Surgical Trials in Melanoma – Past and Future. Invited. 1st Annual Oncology Update: Advances and Controversies. Steamboat Springs, CO, US.
150. 2001. Lunch with the Experts – Sentinel Node Biopsy for Melanoma. Invited. Melanoma 2001 – 11th Annual Cutaneous Malignancy Update. La Jolla, CA, US.
151. 2001. Sentinel Node Evaluation. Invited. Melanoma 2001 – 11th Annual Cutaneous Malignancy Update. La Jolla, CA, US.
152. 2001. Advanced Radioguided Surgery. Invited. 10th Annual General Surgery Forum. Telluride, CO, US.
153. 2001. Sarcoma Debate. Invited. 10th Annual General Surgery Forum. Telluride, CO, US.
154. 2000. Ongoing Trials Around the World. Invited. Sentinel Node 2000 Meeting. Santa Monica, CA, US.
155. 2000. Adjuvant Therapy: Radiation Chemotherapy Immunotherapy: When and Why and Lesson Learned from Recent Melanoma Trials. Invited. 86th Annual Clinical Congress. Chicago, IL, US.
156. 2000. Preoperative Considerations and Operative Technique: How to Do It. Invited. 86th Annual Clinical Congress. Chicago, IL, US.
157. 2000. New Nomenclature and Rating Systems for Melanoma. Invited. Denver American Society for Dermatologic Surgery combined with the American College of Mohs Micrographic Surgery and Cutaneous Oncology Annual Meeting. Denver, CO, US.
158. 2000. Review of Lentigo Maligna Melanoma. Invited. Denver American Society for Dermatologic Surgery combined with the American College of Mohs Micrographic Surgery and Cutaneous Oncology Annual Meeting. Denver, CO, US.
159. 2000. Sentinel Node Evaluation and Other Methods of Evaluating Potential Metastasizing Tumors. Invited. Denver American Society for Dermatologic Surgery combined with the American College of Mohs Micrographic Surgery and Cutaneous Oncology Annual Meeting. Denver, CO, US.
160. 2000. Melanoma Panel Meeting. Invited. National Comprehensive Cancer Network. New York, NY, US.
161. 2000. Breast Organ Site Committee. Invited. American College of Surgeons Oncology Group. Chicago, IL, US.
162. 2000. Soft Tissue Organ Site Committee. Invited. American College of Surgeons Oncology Group Meeting. Chicago, IL, US.
163. 2000. 2nd Annual Melanoma Task Force Meeting. Invited. American Joint Committee on Cancer. Pittsburgh, PA, US.
164. 2000. Stage III Melanoma: Consensus on High-Risk Melanoma. Conference. Melanoma Consensus Conference. Atlanta, GA, US.
165. 2000. Diagnostic and Staging Tools for Melanoma. Invited. Melanoma Consensus Conference. Atlanta, GA, US.
166. 2000. Regional/Nodal Melanoma. Invited. Melanoma Consensus Conference. Atlanta, GA, US.
167. 2000. Surgical Management of Localized Melanoma. Invited. Melanoma at the Millennium. Phoenix, AZ, US.
168. 2000. Excision of the Primary Site: Recommendations from Clinical Trials. Invited. Melanoma at the Millennium. Phoenix, AZ, US.
169. 2000. Regional Limb Perfusion with Tumor Necrosis Factor and Cytotoxic Drugs. Invited. Melanoma at the Millennium. Phoenix, AZ, US.
170. 2000. Update Information for the American Joint Committee on Cancer. Invited. AJCC Melanoma Task Force Meeting. Orlando, FL, US.
171. 2000. Lymphatic Mapping for Melanoma. Invited. Joint Cancer Conference of the Florida Universities. Orlando, FL, US.
172. 2000. Sentinel Node Evaluation. Invited. 10th Annual Melanoma 2000: Cutaneous Malignancy Update Conference. La Jolla, CA, US.
173. 2000. Skin-Sparing Mastectomy. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
174. 2000. Breast Conservation After Neoadjuvant Therapy. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
175. 2000. Breast Biopsy Techniques. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
176. 2000. New Staging System for Melanoma. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
177. 2000. The Sunbelt Melanoma Trial Update. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
178. 2000. Update on Lymphatic Mapping. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
179. 2000. Isolated Limb Perfusion for Malignant Melanoma. Invited. 9th Annual General Surgery Forum. Telluride, CO, US.
180. 2000. Advances in Malignant Melanoma. Invited. 42nd Annual Clinical Conference. Houston, TX, US.
181. 2000. Advances in Malignant Melanoma. Invited. 52nd Annual Symposium on Fundamental Cancer Research. Houston, TX, US.
182. 1999. Melanoma: Challenges for the New Millennium. Invited. 21st Annual Pharmacy Symposium. Houston, TX, US.
183. 1999. Latest Advances in the Evaluation and Treatment of Melanoma. Invited. American Society for MOHS Surgery Conference. Las Vegas, NV, US.
184. 1999. Taskforce Meeting. Invited. American Joint Committee on Cancer. Del Mar, CA, US.
185. 1999. Melanoma and Breast Organ Site Committee Meeting. Invited. American College of Surgeons Oncology Group. Chicago, IL, US.
186. 1999. Sentinel Node Update. Invited. 4th Annual NCCN Conference: Practice Guidelines and Outcomes Data in Oncology. Fort Lauderdale, FL, US.
187. 1999. Contemporary Techniques for Control of Loco-Regional Melanoma. Conference. Recent Advances in Malignant Melanoma. Miami Beach, FL, US.
188. 1999. Update on the Sunbelt Melanoma Trial. Invited. Investigator Meeting. Orlando, FL, US.
189. 1999. Sentinal Node Evaluation. Invited. Melanoma 1999: 9th Annual Cutaneous Malignancy Update. La Jolla, CA, US.
190. 1998. Skin and Soft Tissue Tumors. Invited. 84th Annual Clinical Congress of the American College of Surgeons. Orlando, FL, US.
191. 1998. Lymphatic Mapping and the Significance of Sentinel Node Biopsy. Invited. 84th Annual Clinical Congress of the American College of Surgeons. Orlando, FL, US.
192. 1998. New Surgical Techniques: What’s Proven What’s Not. Invited. 84th Annual Clinical Congress of the American College of Surgeons. Orlando, FL, US.
193. 1998. Surgical Advances in the Treatment of Malignant Melanoma. Invited. The Annual Meeting of the Oklahoma Chapter of the American College of Surgeons. Tulsa, OK, US.
194. 1998. Sentinel Lymph Node Biopsy: Where are we Now. Invited. 3rd Annual Scientific Seminar: Dermatologic Surgery and Cutaneous Oncology. Albuquerque, NM, US.
195. 1998. Surgical Advances in the Treatment of Melanoma. Invited. Symposium on the Multi-Disciplinary Approach to Malignant Melanoma. Bethesda, MD, US.
196. 1998. Surgical Treatment of Early Breast Cancer and the Role of Sentinel Lymph Node Biopsy. Invited. Recent Advances in the Treatment of Breast Cancer Symposium. Louisville, KY, US.
197. 1998. The Role of Lymphoscintigraphy in Extra- and Intraoperative Mapping in Early Stage Melanoma and Breast Cancer. Invited. SNM 43rd Annual Meeting. Houston, TX, US.
198. 1998. Treatment of Early Stage Malignancies. Invited. Joint Cancer Conference. Orlando, FL, US.
199. 1998. Sentinel Lymph Node Mapping in the Management of Early Stage Melanoma and Breast Cancer. Invited. 2nd Annual Nursing Conference Advances in Oncology Nursing. Houston, TX, US.
200. 1998. Sentinel Node Evaluation for Stage I & II Melanoma Patients. Invited. 8th annual Cutaneous Malignancy Update Conference. La Jolla, CA, US.
201. 1998. Sentinel Node Evaluation for Stage I & II Melanoma Patients. Invited. 50th Annual Midwest Cancer Conference. Wichita, KS, US.
202. 1998. Sentinel Node Evaluation in Early Stage Breast Cancer. Invited. 50th Annual Midwest Cancer Conference. Wichita, KS, US.
203. 1997. Surgical Advances in the Treatment of Malignant Melanoma. Invited. 14th Annual CME Cancer Symposium. Springfield, IL, US.
204. 1997. Surgical Advances in the Treatment of Malignant Melanoma. Invited. Perspectives in Melanoma Cancer Conference. Albuquerque, NM, US.
205. 1997. Integration of Molecular Biology in the Diagnosis and Therapy of Solid Tumors. Invited. 83rd Annual Meeting of the American College of Surgeons. Chicago, IL, US.
206. 1997. Lymphatic Mapping and Sentinel Node Biopsy – Panel Discussion. Invited. 83rd Annual Meeting of the American College of Surgeons. Chicago, IL, US.
207. 1997. Melanoma Multidisciplinary Program. Invited. Mount Sinai Comprehensive Cancer Center Cancer Symposium. Miami Beach, FL, US.
208. 1997. Advances in Melanoma Management. Invited. 3rd National Melanoma Faculty Meeting. Hilton Head Island, SC, US.
209. 1997. Sentinel Node Evaluation. Invited. 7th Annual Cutaneous Malignancy Update Conference. La Jolla, CA, US.
210. 1996. An Overview of Malignant Melanoma & Breast Cancer. Invited. U.S. Surgical Cancer Symposium. Norwalk, CT, US.
211. 1996. New Technology of Lymphatic Mapping and Sentinel Node Biopsy. Invited. Advances in Surgical and Medical Treatment of Melanoma Symposium. Rochester, NY, US.
212. 1996. Surgical Approach to Treating the Melanoma Patient. Conference. 49th Annual Symposium on Fundamental Cancer Research: Regulatory Mechanisms in Growth and Differentiation. Houston, TX, US.
213. 1996. Early Detection & Screening for Breast Cancer. Invited. 1996 Reach to Recovery Cancer Forum. Houston, TX, US.
214. 1996. Staging of Melanoma-Intermediate Thickness. Invited. American Osteopathic College of Dermatology Annual Meeting. Las Vegas, NV, US.
215. 1996. Advances in the Diagnosis and Treatment of Malignant Melanoma. Invited. Contemporary Surgery Committee Meeting. San Francisco, CA, US.
216. 1996. Standards of Surgical Care and Ongoing Surgical Trials According to Stage of Disease. Invited. 82nd Annual Clinical Congress of the American College of Surgeons. San Francisco, CA, US.
217. 1996. Moderator - Cutaneous Melanoma in Adults and Children. Invited. 82nd Annual Clinical Congress of the American College of Surgeons. San Francisco, CA, US.
218. 1996. Facilitator - Sentinel Node Biopsy Workshop. Conference. Eastern Cooperative Oncology Group Annual Meeting. Miami Beach, FL, US.
219. 1996. Current Issues in the Treatment of Melanoma. Invited. National Melanoma Faculty Meeting. Coronado, CA, US.
220. 1996. Update and Treatment of Melanoma: ECOG #1684. Invited. Society of Air Force Clinical Surgeons 43rd Annual Symposium. San Antonio, TX, US.
221. 1995. Sentinel Lymph Node Mapping for Melanoma. Invited. Melanoma 1995 - 6th Annual Cutaneous Malignancy Update. La Jolla, CA, US.
222. 1995. Multicenter Selective Lymphadenectomy Trial (MLSLT) Follow-Up. Invited. 81st Annual Clinical Congress American College of Surgeons. New Orleans, LA, US.
223. 1995. Lymphatic Mapping in the Management of Early Stage Melanoma. Invited. 63rd Annual Postgraduate Assembly Omaha Mid-West Clinical Society. Omaha, NE, US.
224. 1995. Sentinel Lymph Node Mapping for Melanoma. Invited. Annual Clinical Assembly of Osteopathic Specialists. New Orleans, LA, US.
225. 1995. Intraoperative Lymphatic Mapping for Melanoma - An Overview. Invited. American Osteopathic College of Dermatology - Current Concepts in Dermatology. Park City, UT, US.
226. 1994. Melanoma Revisited: Alternatives in the Surgical Management of Clinical Stage I Melanoma. Invited. American College of Surgeons Clinical Congress. Chicago, IL, US.
227. 1994. Lessons Learned from the National Surgical Adjuvant Breast Project. Invited. 5th Annual Cancer Conference. Orlando, FL, US.
228. 1994. Natural History and Surgical Treatment of Trunk Melanomas. Invited. Intergroup Melanoma Committee Meeting. Birmingham, AL, US.
229. 1994. Intraoperative Lymphatic Mapping. Invited. W.H.O. Melanoma Programme - Postgraduate Course On Cutaneous Melanoma, US.
230. 1994. Malignant Melanoma. Invited. 46th Annual Meeting of the Southwestern Surgical Conference. Tucson, AZ, US.
231. 1993. Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Management of Early Stage Melanoma. Conference. 45th Annual Meeting of Southwestern Surgical Congress. Monterey, CA, US.
232. 1993. Melanoma: Are Lymph Node Dissections Worthwhile. Invited. 28th Annual San Francisco Cancer Symposium. San Francisco, CA, US.
233. 1993. Primary Surgical Therapy for Cutaneous Melanoma. Invited. Third Annual Cancer Update: Melanoma - Sarcoma Conference. Houston, TX, US.
234. 1992. A Review of the National Surgical Adjuvant Breast Project. Invited. Fourth Annual Melanoma and Breast Conference: Clinical and Research Advances. Lake Buena Vista, FL, US.
235. 1992. Intraoperative Lymphatic Mapping and Sentinel Node Biopsy. Invited. Fourth Annual Melanoma and Breast Conference: Clinical and Research Advances. Lake Buena Vista, FL, US.
236. 1992. Clinical Trial Proposal of Margins of Excision for Thick Melanoma. Invited. WHO Annual Melanoma Programme. Brno, US.
237. 1991. Surgical Approach for Primary Melanoma: Lymph Node Dissection: Primary and Delayed. Invited. American College of Osteopathic Surgeons. San Antonio, TX, US.
238. 1989. Clinical Trials Conducted by the Department of Surgery. Invited. North American Surgical Oncology Group Meeting, US.

International Presentations

1. 2025. Updates on Treating Merkel Cell Carcinoma. Invited. NEMCC Conference - 2025. Stockholm, SE.
2. 2025. Navigating Early-Stage Melanoma: Evolution of Adjuvant Treatment Outcomes and Future Directions. Invited. 15th European Post-Chicago Melanoma/Skin Cancer Meeting. Hamburg, DE.
3. 2025. SLND in Merkel Cell Carcinoma. Invited. 11th World Congress of Melanoma in Conjunction with 21st EADO Congress. Athens, GR.
4. 2025. Sentinel Lymph Node Dissection (SLND) in Cutaneous Squamous Cell Carcinoma. Invited. 11th World Congress of Melanoma in Conjunction with 21st EADO Congress. Athens, GR.
5. 2025. SLND in Melanoma. Invited. 11th World Congress of Melanoma in Conjunction with 21st EADO Congress. Athens, GR.
6. 2024. Global Melanoma Ad Board. Invited. Merck, Inc. Madrid, ES.
7. 2023. Updates on the Adjuvant Therapy for Melanoma. Invited. ESMO. Madrid, ES.
8. 2023. INMC Consortium Meeting. Conference. Updates on Melanoma. Madrid, ES.
9. 2023. MSD-Ad Board for Melanoma. Invited. Merck, Inc. Munich, DE.
10. 2023. Updates on Treating the Melanoma Patient. Invited. ASCO 2023. Chicago, US.
11. 2022. Controversies: Neodadjuvant Therapy in Melanoma. Invited. 12th European Post-Chicago Melanoma/Skin Cancer Meeting. Munich, DE.
12. 2022. Current Trends in Treating the Merkel Cell Tumor. Conference. 2nd International Symposium on Merkel Cell Cancers. Seattle, US.
13. 2021. Annual SSO. Conference. Annual SSO. Virtual Meeting, US.
14. 2020. Primary 2‐year Results of Phase 2, Multicienter, Randomized, Open‐label Trial of Efficacy and Safety Fortalimogene Laherparepvec (T‐VEC) Neoadjuvant Treatment Plus Surgery versus Surgery in Patients with Resectable Stage IIIb‐iVM1a melanoma. Conference. SSO 2020. Virtual, US.
15. 2020. Immunologic Cell Death by a 1000 Injections. Invited. ASCO 2020, US.
16. 2020. The Future of Melanoma Therapy. Invited. 14th Canadian Melanoma Conference. Banff Alberta, CA.
17. 2019. 8th International Cancer Metastasis Congress. Invited. 8th International Cancer Metastasis Congress. San Francisco, US.
18. 2019. International Merkel Cell Carcinoma Symposium. Conference. International Merkel Cell Carcinoma Symposium. Tampa, US.
19. 2019. MERCK – Global Melanoma Advisory Board Meeting. Conference. MERCK, SZ.
20. 2019. Identification of Risk Patients by Gene Expression Profiling. Invited. 9th European Post-Chicago Melanoma/Skin Cancer Meeting, Results and Interpretations of ASCO Presentation 2019: Interdisciplinary Global Conference on New in Melanoma/Skin Cancer. Munich, DE.
21. 2019. Update on Neoadjuvant/Intralesional Treatment for Melanoma. Invited. 9th European Post-Chicago Melanoma/Skin Cancer Meeting, Results and Interpretations of ASCO Presentation 2019: Interdisciplinary Global Conference on New in Melanoma/Skin Cancer. Munich, DE.
22. 2019. CLND for Sentinel Node Positive Patients - YES. Invited. 9th European Post-Chicago Melanoma/Skin Cancer Meeting, Results and Interpretations of ASCO Presentation 2019: Interdisciplinary Global Conference on New in Melanoma/Skin Cancer. Munich, DE.
23. 2019. PV-10, Rose Bengal. Invited. 9th European Post-Chicago Melanoma/Skin Cancer Meeting, Results and Interpretations of ASCO Presentation 2019: Interdisciplinary Global Conference on New in Melanoma/Skin Cancer. Munich, DE.
24. 2019. 9th European Post‐Chicago Melanoma/Skin CA. Conference. Hauschild/Garbe, DE.
25. 2019. ASCO. Conference. ASCO 2019. Chicago, US.
26. 2019. Adjuvant and Neoadjuvant Therapy for High Risk and Recurrent Melanoma. Invited. Euroclinic Oncology Center (Victoria Hospital) Iasi. Iasi, RO.
27. 2019. Management of a Positive SLNB in the Era of MSLT-2 and DeCOG. Invited. 72nd Annual Cancer Symposium (SSO). San Diego, US.
28. 2019. Meet the Professor Breakfast Session. Invited. SSO 2019. San Diego, US.
29. 2019. Treatment Plus Surgery versus Surgery for Resectable Stage IIIB-IVM1a Melanoma. Invited. 72nd Annual Cancer Symposium (SSO). San Diego, US.
30. 2019. SSO 2019 TVEC Presentation. Conference. SSO 2019 TVEC Presentation. San Diego, US.
31. 2019. SSO 2019. Conference. SSO 2019. San Diego, US.
32. 2018. Intralesional Combination Therapies. Invited. European Association of Dermato Oncology and Interdisciplinary Melanom/Skin Cancer Centres. Barcelona, ES.
33. 2018. Do the Results of the Completion Lymph Dissection Trials Diminish the Clinical Relevance of SLN Biopsy?. Invited. International Sentinel Node Society. Tokyo, JP.
34. 2018. What's New in Other Cutaneous Malignancies. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
35. 2018. Future Directions: Surgery In Melanoma IV. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
36. 2018. How To Integrate Intralesional Therapy In Clinical Practice. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
37. 2018. Intralesional and Regional Therapy. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
38. 2018. Sentinel Node Biopsy, Is it Still Necessary? Completion Lymphadenectomy After MSLT2: To Do or Not To Do?. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
39. 2018. Putting It All Together - Case Presentation. Invited. Brazilian Melanoma Group. Salvador de Bahia, BR.
40. 2018. Lymph Node Management: SLNB vs. Completion Lymphadenectomy. Invited. Chinese Society of Clinical Oncology. Beijing, CN.
41. 2018. Advances in Melanoma Management. Invited. Association of Physician Assistants in Oncology (APAO). San Diego, US.
42. 2018. Medical Oncology/Surgical Joint Session: Neoadjuvant Therapy. Invited. 12th Canadian melonoma conference. Banff, Alberta, CA.
43. 2018. Dermatology and Surgical Oncology Joint Session: Imaging in Melanoma: Staging and Surveillance. Invited. 12th Canadian melanoma conference. Banff, Alberta, CA.
44. 2018. Neoadjuvant approaches to regionaly advanced and metastatic melanoma. Invited. AMGEN. Jacksonville, US.
45. 2017. Oncolytic immunotherapies: The future of neoadjuvant therapy?. Invited. ESMO Immuno Oncology Congress. Geneva, CH.
46. 2017. Linfadenectomy Pros and contra. Invited. 3PSolution. Naples, IT.
47. 2017. Immunotherapy Combined with Other Drugs: Where Are We Now and Where Are We Heading?. Invited. XIII Brazilian Clinical Oncology Congress. Rio de Janeiro, BR.
48. 2017. Experience with Neoadjuvant Therapy for Patients With Advanced Nodal Metastases. Invited. 9th World Congress of Melanoma. Brisbane, AU.
49. 2017. Who, If Anyone, With A Positive Sentinel Node Should Get An Immediate Completion Lymph Node Dissection?. Invited. 9th World Congress of Melanoma. Brisbane, AU.
50. 2017. Presentation of No Case. Invited. 9th World Congress of Melanoma. Brisbane, AU.
51. 2017. Advances in surgical management of breast cancer. Invited. Salt Cancer Initiative, Inc. Hanoi, VN.
52. 2017. Immunotherapy and how it changed the melanoma landscape paving the road for other soid tumors. Invited. Salt Cancer Initiative, Inc. Hanoi, VN.
53. 2017. Advances in Melanoma Management. Invited. Partners in Cancer Care. San Diego, US.
54. 2017. Is Surgery Replaced By Systemic Treatment In Stage IV Melanomas?. Invited. AMGEN. Munich, DE.
55. 2017. Liver Metastasis: Surgery, Perfusion or Chemosaturation?. Invited. AMGEN. Munich, DE.
56. 2017. Regional Therapies for Melanoma. Invited. 70th Annual Cancer Symposium of the Society of Surgical Oncology 2017. Seattle, US.
57. 2017. For Patients with Resected Sentinel Node Positive Melanoma, Routine Radiographic Surveillance Is Essential. Invited. 70th Annual Cancer Symposium of the Society of Surgical Oncology 2017. Seattle, US.
58. 2017. Amgen Clinical Considerations for Treatment in Advanced Melanoma. Invited. 70th Annual Cancer Symposium of the Society of Surgical Oncology 2017. Seattle, US.
59. 2017. Evolving Role of Surgery in the Immunotherapy Era: Management of Complex Situations. Invited. 11th Canadian Melanoma Conference. Whistler, CA.
60. 2015. Melanoma Clinical Cases. Invited. MERCK Inc. Sao Paulo, BR.
61. 2015. Surgical Management of Breast Cancer Post Neoadjuvant Treatment. Invited. IV Ecuadorian Mastology Congress. Guayaquil, EC.
62. 2015. Sentinel Node in the Multidisciplinary Management of Breast Cancer. Invited. IV Ecuadorian Mastology Congress. Guayaquil, EC.
63. 2015. Management of Sentinel Node Post Neoadjuvant. Invited. IV Ecuadorian Mastology Congress. Guayaquil, EC.
64. 2015. LNS (+) is the Same as Lymphadenectomy?. Invited. 11th Brazilian Melanoma Conference. Goiania, BR.
65. 2015. Melanoma Resection Overview. Invited. Bristol Myers Squibb. Goiania, BR.
66. 2015. Melanoma Clinical Case Discussion. Invited. Bristol Myers Squibb. Goiania, BR.
67. 2015. What's the Best Way to Relieve Symptoms in Metastatic Patients with Local Symptoms: A Surgical Perspective. Invited. 11th Brazilian Melanoma Conference. Goiania, BR.
68. 2015. Surgical Treatment: What to Expect from Intratumor Treatments Like PV-10, T-VEC and Others. Invited. 11th Brazilian Melanoma Conference. Goiania, BR.
69. 2014. Sentinel Node and Its Importance in Melanoma. Invited. Bristol Myers Squibb. Cancun, MX.
70. 2014. New Challenges in the Treatment of Melanoma - Surgical Treatment. Invited. Bristol Myers Squibb. Cancun, MX.
71. 2014. When to Use a Regional Approach Versus a Systemic Approach for Regionally Metastatic Melanoma. Invited. 67th Annual Society of Surgical Oncology. Phoenix, US.
72. 2013. Multi-Disciplinary Approach to Treating the Melanoma Patient. Invited. Merck Sharp & Dohme Limited. Moscow, RU.
73. 2013. Treatment of Metastatic Melanoma. Invited. Merck Sharp & Dohme Limited. Moscow, RU.
74. 2013. The melanoma guidelines - Lead panel discussant/presenter. Invited. Merck Sharp & Dohme Limited. Moscow, RU.
75. 2013. State of the Art Surgery: A Global View. Invited. Merck Sharp & Dohme Limited. Moscow, RU.
76. 2013. Surgical Approach of Metastatic Melanoma in the Target Drug Age. Invited. 10th Brazilian Conference on Melanoma. Belo Horizonte, BR.
77. 2013. What is Missing at Melanoma Staging for Melanoma Prognosis?. Invited. 10th Brazilian Conference on Melanoma. Belo Horizonte, BR.
78. 2013. Intransit Metastatic Melanoma: Role of Intratumoral Treatment Modalities. Invited. Joint International Oncology Congress. San Francisco, US.
79. 2013. Sentinel Lymph Node Mapping for Melanoma. Invited. Merck, Inc. Panama City, PA.
80. 2013. Surgical Resection for Stage IV Melanoma. Invited. Merck, Inc. Panama City, PA.
81. 2013. State of the Art Surgery: A Global View of America. Invited. Merck, Inc. Panama City, PA.
82. 2012. The Molecular Subtypes of Individualized Treatment in Breast Cancer. Invited. Hebei Anti-Cancer Association. Shijiazhuang, CN.
83. 2012. Current Controversies in the Surgical Treatment of Breast Cancer. Invited. Hebei Anti-Cancer Association. Shijiazhuang, CN.
84. 2012. The Evolving Melanoma Landscape: Impact on Surgical Management. Invited. Hellenic Society of Dermatology and Venereology. Pylos-Messinia, GR.
85. 2012. The New Melanoma Landscape: Impact on Stage Specific Melanoma. Invited. 7th Canadian Melanoma Conference. Banff, Alberta, CA.
86. 2011. Potential for IL Therapy Worldwide. Invited. Melanoma Roundtable Discussion. Tampa, US.
87. 2011. Loco-Regional Surgery in Patients with Advanced Breast Cancer. Invited. Peruvian Cancer Society. Lima, PE.
88. 2011. Clinical Cases for Early-Stage Breast Cancer. Invited. Peruvian Cancer Society. Lima, PE.
89. 2011. Management of the Axilla in Early-Stage Breast Cancer. Invited. Peruvian Cancer Society. Lima, PE.
90. 2011. Sentinel Lymph Node Biopsy for Thin Melanoma-A Debate/PRO. Invited. 64th Society of Surgical Oncology. San Antonio, US.
91. 2011. ILI and ILP, Recent Data, Future Directions. Invited. 64th Society of Surgical Oncology. San Antonio, US.
92. 2011. Sentinel Node Biopsy Indication 2011. Invited. Canadian Melanoma Society. Banff, CA.
93. 2010. Caring for the Breast Cancer Patient. Invited. ISNS 2010. Pacifico Yokohama, JP.
94. 2010. Sentinel Lymph Node Biopsy in Melanoma. Invited. Asociacion Colombiana de Hematologia Oncologia. Armenia, CO.
95. 2010. The Impact of Neo-Adjuvant Chemotherapy on the Surgical Management of Breast Cancer. Invited. XXVIII National Congress of Oncology. Cancun, MX.
96. 2010. Axillary Dissecton for Sentinel Node Positive Breast Cancer: The Controversy Continues. Invited. XXVIII National Congress of Oncology. Cancun, MX.
97. 2010. Multi-Disciplinary Approach to Advanced Regional Lymph Node Disease in Melanoma Patients. Invited. XXVII National Congress of Oncology. Cancun, MX.
98. 2010. Revised Melanoma Staging Criteria. Invited. American Osteopathic College of Dermatology. San Francisco, US.
99. 2010. Melanoma Case Studies: A Panel Discussion. Invited. American Osteopathic College of Dermatology. San Francisco, US.
100. 2010. A Surgeon's View of Advances in Immunotherapy for Melanoma: Advances, Past Failures and Future Directions. Invited. Glaxo Smith Kline/Satellite Symposium/6th European Association of Dermatologic Oncology. Athens, GR.
101. 2010. An Evidence-Based Approach to Excision Margins of Melanoma. Invited. 6th European Association of Dermatologic Oncology. Athens, GR.
102. 2010. Surgical Advances in the Treatment of Melanoma. Invited. University of Illinois Medical Center/Warren H. Cole Society. Chicago, US.
103. 2010. Managing the Melanoma Patient - surgery and Sentinel Node Biopsy Considerations. Invited. American Academy of Dermatology Association. Miami, US.
104. 2009. Interferon and vaccines in treating melanoma. Invited. National Cancer Congress of Ecuador. Manta, EC.
105. 2009. Sentinel lymph node biopsy in melanoma. Invited. National Cancer Congress of Ecuador. Portoviejo, EC.
106. 2009. The role of anti-idiotypic vaccines in the treatment of cancer and haematological diseases. Invited. XVIII Brazilian Congress of Cancerology-CONCAN 2009. Curitiba, BR.
107. 2009. The surgical treatment of primary melanoma. Invited. XVIII Brazilian Congress of Cancerology-CONCAN 2009. Curitiba, BR.
108. 2009. Axillary lymph node dissection after positive sentinel lymph node biopsy. Invited. XVIII Brazilian Congress of Cancerology-CONCAN 2009. Curitiba, BR.
109. 2009. Current aspects of cutaneous melanoma treatment. Invited. XVIII Brazilian Congress of Cancerology-CONCAN 2009. Curitiba, BR.
110. 2009. Panel Discussion: Multidisciplinary treatment of breast cancer. Invited. Peruvian Cancer Oncology Congress. Lima, PE.
111. 2009. Current role of surgery in the treatment of breast cancer. Invited. Peruvian Cancer Oncology Congress. Lima, PE.
112. 2009. Multifocal and multicentric breast cancer and nipple sparing mastectomy. Invited. Peruvian Cancer Oncology Congress. Lima, PE.
113. 2009. Updates in adjuvant therapies for melanoma. Invited. Annual Meeting of the American Society of Clinical Oncology. Orlando, US.
114. 2009. Panel Discussion on Sentinel Nodes - Pros and Cons. Invited. 7th World Congress on Melanoma. Hofburg, AT.
115. 2009. Sentinel lymph node: Pros and Cons - Completion dissection is indicated for minimal disease. Invited. 7th World Congress on Melanoma. Hofburg, AT.
116. 2009. Surgery; Margins of Excision: An evidence-based approach for the clinic. Invited. 7th World Congress on Melanoma. Hofburg, AT.
117. 2009. Sentinel lymph node biopsy in melanoma. Invited. 12th World Congress on Cancers of the Skin. Tel Aviv, IL.
118. 2009. Controversies in immediate breast cancer reconstruction. Invited. 2nd International Breast Cancer Conference, KW.
119. 2009. Oncoplastic techniques for locally advanced breast cancer. Invited. 2nd International Breast Cancer Conference, KW.
120. 2009. Great Debates in Surgical Oncology: PRO: Completion lymphadenectomy for melanoma metastasis to sentinel lymph nodes. Invited. 62nd Annual Society of Surgical Oncology. Phoenix, US.
121. 2008. EADO Session: Non-surgical treatment of non-melanoma skin cancers (actinic keratoses, invasive squamous cell carcinoma and basal cell carcinoma). Invited. 7th International Conference of Adjuvant Therapy on Malignant Melanoma (ICATMM) and 4th European Association of Dermato-Oncology Congress (EADO). Marseille, FR.
122. 2008. Surgical adjuvant therapy: elective node dissection according to sentinel node status: PRO. Invited. 7th International Conference of Adjuvant Therapy on Malignant Melanoma (ICATMM) and 4th European Association of Dermato-Oncology Congress (EADO). Marseille, FR.
123. 2008. Stage III Melanoma: A Multi-Modality Approach to a Complicated Regional Disease. Invited. 61st Annual Society of Surgical Oncology. Chicago, US.
124. 2008. Isolated Limb Perfusion vs. Limb Infusion Therapy. Conference. 3rd International Symposium on Regional Cancer Therapies. Palm Desert, US.
125. 2007. Evolution and Actual Status of Sentinel Node in Melanoma. Invited. 1st International Course, Sentinel Node, Mexico 2007. Cancun, MX.
126. 2007. Results Management, Surgical Perspectives. Invited. Ist International Course, Sentinel Node, Mexico 2007. Cancun, MX.
127. 2007. Interactive Surgical Session, How Do I Perform the Surgery?, Live Transmission from the Surgery Room. Invited. 1st International Course, Sentinel Node, Mexico 2007. Cancun, MX.
128. 2007. Melanoma - Breakfast with the Experts. Invited. 1st International Course, Sentinel Node, Mexico 2007. Cancun, MX.
129. 2007. Adjuvant Treatment in Melanoma, When and Whom? A Roundtable Discussion. Invited. 1st International Course, Sentinel Node, Mexico 2007. Cancun, MX.
130. 2007. The Safety of Breast Conserving Surgery in Patients after Neoadjuvant Chemotherapy. Invited. IX Venezuelan Mastology Congress and Venezuelan Mastology Society. Maracaibo, VE.
131. 2007. Sentinel Node Symposium: Micrometastasis: Axillary Dissection?. Invited. IX Venezuelan Mastology Congress and Venezuelan Mastology Society. Maracaibo, VE.
132. 2007. Needle Localization Biopsy or other Techniques of Non-Palpable Breast Lesions: Technical Considerations. Invited. IX Venezuelan Mastology Congress and Venezuelann Mastology Society. Maracaibo, VE.
133. 2007. Bilateral Prophylactic Mastectomy Efficacy in Women at High Risk. Invited. IX Venezuelan Mastology Congress and Venezuelan Mastology Society. Maracaibo, VE.
134. 2007. Future Directions of Melanoma Staging. Invited. 1st World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers. Barcelona, ES.
135. 2007. Is SLNB Appropriate in 2007? If So, In What Patients?. Invited. 1st World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers. Barcelona, ES.
136. 2007. What is the Prognostic Impact of the Sentinel Lymp Node in Cutaneous Melanoma?. Invited. 7th Brazilian Conference on Melanoma. Porto Alegre, BR.
137. 2007. ASCO Highlights for Melanoma. Invited. 2007 Oncology Highlights: New from the 43rd ASCO Annual Meeting. Las Vegas, US.
138. 2007. Sentinel Node Staging in Melanoma: The Standard of Care? The US Position. Invited. 11th World Congress on Cancers of the Skin. Amsterdam, NL.
139. 2007. Clinical and Immunological in Patients with Malignant Melanoma Treated with a Dendritic Cell-Based Vaccine. Preliminary Report from a Multi-Institutional Phase II Clinical Trial. Invited. 2007 ASCO Annual Meeting. Chicago, US.
140. 2007. Advances in Clinical Management and Assessment of Melanoma Prognosis. Invited. Annual American Association for Cancer Research Meeting. Los Angeles, US.
141. 2006. Surgical Treatments in the Melanoma Patient. Invited. 5th Biennial International Sentinel Lymph Node Society Meeting, Sentinel Node Biopsy: New Boundaries. Rome, IT.
142. 2006. Lymphatic Mapping and Sentinel Node Biopsy in the Melanoma Patient. Invited. 5th Biennial International Sentinel Node Society Meeting, Sentinel Node Biopsy: New Boundaries. Rome, IT.
143. 2006. Difficulties in Dealing with the Melanoma Patient: How to Handle. Invited. Annual Latin American Oncology Congress. Margarita Island, VE.
144. 2006. Surgical Treatment for Melanoma. Invited. Annual Latin American Oncology Congress. Margarita Island, VE.
145. 2006. Melanoma Case Studies: Beyond Stage I. Invited. 11th Annual American Society for MOHS Surgery Clinical Symposium - Dermatologic Surgery: Focus on Skin Cancer. Grand Bahama Island, BS.
146. 2006. Breast Reconstruction and Oncoplastic. Invited. Middle East Breast Cancer Conference. Bsalim, LB.
147. 2006. Surgery In Primary Melanoma: Margins According to Depth and Location. Invited. IV Interdisciplinary Course in Oncology. Oviedo, ES.
148. 2006. Conservative Surgery and Sentinel Lymph Node Biopsy. Invited. Middle East Breast Cancer Conference. Bsalim, LB.
149. 2006. Sentinel Node: Indications, Surgical Technique, and Results. Invited. IV Interdisciplinary Course in Oncology. Oviedo, ES.
150. 2006. Panel Discussion: The Optimal Margin of Resection for All Melanomas is 1 cm. Invited. 59th Annual Meeting of the Society of Surgical Oncology. San Diego, US.
151. 2006. Role of PCR Analysis in Lymph Nodes in Melanoma. Invited. 3rd International Symposium on Melanoma and other Cutaneous Malignancies. New York, US.
152. 2005. Should SLN Biopsy Be Done for All Patients with Melanoma. Invited. 2nd International Symposium on Melanoma and Other Cutaneous Malignancies. New York, US.
153. 2005. New Trends in Vaccine Therapy. Invited. 6th World Congress on Melanoma. Vancouver, CA.
154. 2005. Sentinel Lymph Node Biopsy: does it Prolong Survival. Invited. 6th World Congress on Melanoma. Vancouver, CA.
155. 2005. Large ALM of the Thumb or Heel. Invited. 6th World Congress on Melanoma. Vancouver, CA.
156. 2005. The Future of Surgery for Melanoma. Invited. Post American Society of Clinical Oncology Symposium. Short Hills, US.
157. 2005. Surgical Approaches to Regional Disease and Treatment of Metastatic Disease. Invited. 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, US.
158. 2003. Update on Sentinel Node Biopsy for the Melanoma Patient. Invited. American College of Surgeons Oncology Group Semiannual Meeting. Montreal, CA.
159. 2002. Discussion of Current Treatments for Malignant Melanoma. Invited. WHO Programme Committee Meeting. Milan, IT.
160. 2002. Sentinel Node Technique for Staging and Treatment Decisions for Melanoma. Invited. 2002 Annual Meeting of the American Society of Clinical Oncology. Orlando, US.
161. 2002. Sentinel Node Biopsy for Breast Cancer. Invited. XIV Annual International Breast Conference. Beirut, LB.
162. 2002. Controversies in Treating the Breast Cancer Patient. Invited. XIV Annual International Breast Conference. Beirut, LB.
163. 2002. Breast Reconstruction in Breast Cancer Patients. Invited. Oncology Conference. Kuwait City, KW.
164. 2002. DCIS: Treatment Options – Surgery vs Surgery with Radiation Therapy. Invited. Oncology Conference. Kuwait City, KW.
165. 2002. Minimally Invasive Approaches to the Surgical Management of Breast Cancer. Invited. Oncology Conference. Kuwait City, KW.
166. 2002. Predictive Factors in Breast Cancer. Invited. Oncology Conference. Kuwait City, KW.
167. 2002. Sentinel Lymph Node Mapping for Malignant Melanoma. Invited. XXXIII Peruvian and International Congress of Surgery Meeting. Lima, PE.
168. 2002. Sentinel Lymph Node Mapping for Breast Cancer. Invited. XXXIII Peruvian and International Congress of Surgery Meeting. Lima, PE.
169. 2001. Sentinel Node Technique for Staging and Treatment Decisions for Melanoma. Invited. 2001 Annual Meeting of the American Society of Clinical Oncology. San Francisco, US.
170. 2001. Controversial Issues in the Surgical Management of DCIS. Invited. 5th Middle Eastern Oncology Congress. Beirut, LB.
171. 2001. Pathological Scoring of DCIS. Invited. 5th Middle Eastern Oncology Congress. Beirut, LB.
172. 2001. The Biologic Relevance of Micrometastases for Melanoma. Invited. 5th World Conference on Melanoma. Venice, IT.
173. 2001. Update on Lymphatic Mapping for Melanoma. Invited. 2001 American Osteopathic College of Dermatology Meeting. Cancun, MX.
174. 2001. New Staging Criteria for Melanoma. Invited. 2001 American Osteopathic College of Dermatology Meeting. Cancun, MX.
175. 2000. Advances Techniques in the Management of Breast Cancer. Invited. 32nd World Congress of the International Colleges of Surgeons Meeting. Singapore, US.
176. 2000. Breast Cancer – Sentinel Node Technology. Invited. 32nd World Congress of the International Colleges of Surgeons Meeting. Singapore, US.
177. 2000. The Biologic Relevance of Micrometastases. Invited. WHO Melanoma Programme Review Meeting. Szeged, HU.
178. 2000. Sentinel Lymph Node Biopsy and Therapeutic Node Dissection for Melanoma. Invited. Henry Shibata Lecture for the Canadian Society of Surgical Oncology Meeting. Toronto, CA.
179. 2000. Sentinel Lymphadenectomy Breast Cancer. Invited. 53rd Annual Meeting of the Society of Surgical Oncology. New Orleans, US.
180. 1999. What is the Place for Sentinel Node Biopsy in the Head and Neck. Invited. Eastern Great Lakes Head and Neck Oncology Association 23rd Annual Meeting. Hamilton, CA.
181. 1999. Surgery for Melanoma: Margins and Lymphadenectomy Metastases. Invited. 11th Brazilian Congress of Clinical Oncology. Florianopolis, BR.
182. 1999. Soft Tissue Sarcomas. Invited. XIV Argentine Congress of Oncology. Buenos Aires, AR.
183. 1999. Progresses in the Surgical Treatment of Melanoma. Invited. XIV Argentine Congress of Oncology. Buenos Aires, AR.
184. 1999. Meeting with Experts on Melanoma. Invited. XIV Argentine Congress of Oncology. Buenos Aires, AR.
185. 1999. Multimodality Approaches to Malignant Melanoma. Invited. 2nd UICC Cancer Management Meeting. Antwerp, BE.
186. 1999. Sentinel Lymphadenectomy: Pitfalls in the Nuclear Medicine Suite and the Operating Room. Invited. 1st International Congress on the Sentinel Node in Diagnosis and Treatment of Cancer. Amsterdam, NL.
187. 1999. Radioguided Surgery and Lymphatic Mapping. Invited. 52nd Annual Cancer Symposium for the Society of Surgical Oncology Meeting. Orlando, US.
188. 1999. What to do with Internal Mammary Sentinel Nodes: A Case Presentation. Invited. 52nd Annual Cancer Symposium for the Society of Surgical Oncology Meeting. Orlando, US.
189. 1999. Malignant Melanoma. Invited. 52nd Annual Cancer Symposium for the Society of Surgical Oncology Meeting. Orlando, US.
190. 1999. Surgical Conservation of the Breast vs Radical Mastectomy. Invited. X International Congress of General Surgery. Monterrey, MX.
191. 1999. Biopsy of the Sentinel Node: Is Axillary Dissection Necessary. Invited. X International Congress of General Surgery. Monterrey, MX.
192. 1998. Development and Clinical Application of the Sentinel Node Concept for Melanoma Patients. Invited. International Conference for Lymphatic Metastasis and Sentinel Lymphadenectomy. Berlin, DE.
193. 1998. Melanoma. Invited. XVII UICC International Cancer Congress. Rio de Janeiro, BR.
194. 1998. Are Micrometastases Important. Invited. XVII UICC International Cancer Congress. Rio de Janeiro, BR.
195. 1998. Recent Advances in Malignant Melanoma. Invited. Royal College of Surgeons of Thailand’s 23rd Annual Meeting. Pathia, TH.
196. 1998. State of the Art Treatment of Melanoma at the National Cancer Institute - Panel Discussion. Invited. 23rd Annual Meeting. Pathia, TH.
197. 1998. Current Management of Malignant Melanoma. Invited. Royal College of Surgeons of Thailand’s 23rd Annual Meeting. Pathia, TH.
198. 1998. MD Anderson Experience - Lymphatic Mapping for Melanoma and Breast Cancer. Invited. 9th Congress of the European Society of Surgical Oncology. Lausanne, CH.
199. 1998. Melanoma Mapping. Invited. 51st Annual Meeting of the Society of Surgical Oncology. San Diego, US.
200. 1998. Advances in the Staging and Surgical Treatment of Melanoma. Invited. 51st Annual Meeting of the Society of Surgical Oncology. San Diego, US.
201. 1997. Epidemiologic Factors and the Role of Sentinel Node Mapping. Invited. European Cancer Conference. Hamburg, DE.
202. 1997. Therapeutic Perspectives in the Management of Malignant Melanoma. Invited. European Cancer Conference. Hamburg, DE.
203. 1997. Malignant Melanoma. Invited. The First UICC Cancer Management Meeting. Vienna, AT.
204. 1997. Nodal Failure After Lymphatic Mapping and Negative Sentinel Lymph Node Biopsy in Stage I or II Melanoma Patients. Invited. 4th World Conference on Melanoma. Sydney, AU.
205. 1997. Recent Advances in the Treatment of Malignant Melanoma. Invited. 4th World Conference on Melanoma. Sydney, AU.
206. 1997. Prognostic Significance of the Sentinel Lymph Node in Stage I or II Melanoma Patients. Invited. 4th World Conference on Melanoma. Sydney, AU.
207. 1997. Management of Malignant Melanoma. Invited. 33rd Annual Meeting of the American Society of Clinical Oncology. Denver, US.
208. 1997. Recent Surgical Laboratory and Therapeutic Advances in the Management of Cutaneous Malignant Melanoma. Invited. 50th Annual Cancer Symposium for the Society of Surgical Oncology. Chicago, US.
209. 1997. Impact of Intraoperative Lymphatic Mapping and Sentinel Lymph Node Biopsy on Melanoma Patient Staging and Clinical Outcomes. Invited. 50th Annual Cancer Symposium for the Society of Surgical Oncology. Chicago, US.
210. 1997. Lymphatic Mapping and Sentinel Node Biopsy for Melanoma. Invited. 50th Annual Cancer Symposium for the Society of Surgical Oncology. Chicago, US.
211. 1997. Breast Conservation Surgery After Induction Chemotherapy for Locally Advanced Breast Carcinoma. Invited. Third National Breast Congress Izmir Society for Breast Diseases Symposium. Izmir, TR.
212. 1997. NSABP Updates. Invited. Third National Breast Congress. Izmir, TR.
213. 1997. Malignant Melanoma. Invited. Current Controversies, Future Perspectives. Barcelona, ES.
214. 1997. Early Detection Diagnosis and the Role of Sentinel Node Mapping. Invited. Current Controversies, Future Perspectives. Barcelona, ES.
215. 1996. Elective Lymphadenectomy: Controversies in Perspective. Invited. International Symposium of Cutaneous Malignant Melanoma Annual Meeting. Sao Paulo, BR.
216. 1996. Surgical Management of Malignant Melanoma. Invited. The European Society of Surgical Oncology Meeting. Dublin, IE.
217. 1996. Lymphatic Mapping and Sentinel Node Biopsy. Invited. TriClinica Oncology Focus: Melanoma Speakers’ Bureau Meeting. Montreal, CA.
218. 1996. Sarcoma. Invited. National Cancer Registrars Association 22nd Annual Education Conference. New Orleans, US.
219. 1996. Skin and Melanoma. Invited. National Cancer Registrars Association 22nd Annual Education Conference Cancer Management Course. New Orleans, US.
220. 1996. Proposal for a New Staging System for Cutaneous Melanoma. Invited. 32nd Annual Meeting of the American Society of Clinical Oncology. Philadelphia, US.
221. 1996. Session Chair- Axillary Endoscopic Lymphadenectomy in Breast Cancer. Invited. 9th International Congress on Breast Disease. Houston, US.
222. 1996. Session Chair - Telemedicine and Breast Cancer. Invited. 9th International Congress on Breast Diseases. Houston, US.
223. 1996. Update and Treatment of Melanoma: ECOG #1684. Invited. 49th Annual Meeting of the Society of Surgical Oncology. Atlanta, US.
224. 1995. Results of Randomized Surgical Trials for Melanoma and Multidisciplinary Treatment of Distant Melanoma Metastases. Invited. The Sixth World Congress On Cancers Of The Skin. Buenos Aires, AR.
225. 1995. Isolated Limb Perfusion (ILP) Circuit Leak Detected by Technetium-99 (99-Tc) Labeled RBC’s. Invited. The Society of Surgical Oncology’s 48th Annual Meeting. Boston, US.
226. 1993. Conservative Breast Surgery In-Depth Review. Invited. Surgical Oncology Conference, US.
227. 1993. Intra-Operative Lymphatic Mapping and Sentinel Node Biopsy. Invited. W.H.O. Meeting. Crete, GR.
228. 1993. Margins of Excision for Melanoma. Invited. W.H.O. Meeting. Crete, GR.
229. 1993. Highlights in Breast Cancer. Invited. The Universita Cattolica Del Sacro Cuore. Rome, IT.
230. 1993. Margins of Excision for Primary Melanomas Update of Clinical Trials. Invited. Third International Conference on Melanoma. Venice, IT.
231. 1993. Lymphatic Mapping and Sentinel Node Biopsy in the Management of Early Stage Melanomas. Invited. Third International Conference on Melanoma. Venice, IT.
232. 1993. Expanding the Role of Intraoperative Lymphatic Mapping and Sentinel Node Biopsy in the Management of Primary Melanoma. Invited. Society of Surgical Oncology Meeting. Los Angeles, US.
233. 1992. Update on the Intergroup Melanoma Trial. Invited. Special International Columbus Meeting on Surgical Oncology. Genoa, IT.
234. 1992. Elective Lymph Node Dissection: Results of Non-Randomized Trials. Invited. Special International Columbus Meeting on Surgical Oncology. Genoa, IT.
235. 1992. Innovations in Melanoma Therapy. Invited. Nuevos Abodajes Terapeuticos En Oncologia. Mexico City, MX.
236. 1992. State of the Art Breast Cancer Therapy. Invited. Nuevos Abordaje Terapeuticos En Oncologia. Mexico City, MX.
237. 1992. Participation in the Programme Planning Committee. Invited. Third International Conference on Melanoma. Milan, IT.
238. 1989. Patterns of Failure in Anorectal Melanoma a Guide to Surgical Therapy. Invited. Society of Surgical Oncology Annual Meeting, US.

Formal Peers

1. 2024. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
2. 2023. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
3. 2022. Management of Malignant Melanoma. Visiting. San Diego, CA, US.
4. 2022. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
5. 2021. NCCN Melanoma Panel Meeting – Day #2. Invited. Virtual Meeting, US.
6. 2021. NCCN Melanoma Panel Meeting – Day #1. Invited. Virtual Meeting, US.
7. 2021. Surgical Oncology Fellows Conference – Part Two Lecture Series. Visiting. Houston, TX, US.
8. 2021. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
9. 2020. EISAI: ESMO Virtual Meeting. Invited. Virtual Meeting, US.
10. 2020. Updates on the Treatments for the Melanoma Patient. Invited. Phoenix, AZ, US.
11. 2020. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
12. 2020. James Cancer Center Grand Rounds. Invited. Columbus, OH, US.
13. 2019. Melanoma Slide Review. Invited, Barcelona, ES.
14. 2019. European Society for Medical Oncology (ESMO). Invited, Barcelona, ES.
15. 2019. The Art and Science of Managing the New Melanoma Landscape 6th Annual Collaborative Conference. Visiting. Houston, TX, US.
16. 2019. 2019 Am. Radium Society Meeting. Invited. Dans Point, CA, US.
17. 2019. Neracare Meeting. Invited. San Diego, CA, US.
18. 2019. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
19. 2018. The Art and Science of Managing the New Melanoma Landscape 5th Annual Collaborative Conference. Visiting. Houston, TX, US.
20. 2018. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
21. 2018. Advances in Melanoma: Treatment Controversies and Innovations. Invited. Hartford, CT, US.
22. 2018. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
23. 2017. Update on surgical approaches to the treatment of melanoma. Invited. New Orleans, LA, US.
24. 2017. The Art and Science of Managing the New Melanoma Landscape 4th Annual Collaborative Conference. Visiting. Houston, TX, US.
25. 2017. Advances in melanoma prevention, detection, research and neoadjuvant clinical trials. Visiting. Houston, TX, US.
26. 2017. Surgical Treatment of Melanoma: Evolving New Guidelines. Invited. Tulsa, OK, US.
27. 2017. Regional Therapies Conference for Melanoma: The optimal method to treat in transit metastases. Invited. Snowbird, UT, US.
28. 2016. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
29. 2015. Systemic Therapy for High-Risk Melanoma Patients: Current Status and Future Directions. Visiting. Columbus, OH, US.
30. 2015. Surgical Strategies in the New Melanoma Treatment Landscape: New Opportunities and Evolving Paradigms. Visiting. Columbus, OH, US.
31. 2015. Perspective from decades of SLN biopsy for cutaneous melanoma and SLN biopsy cases for Discussion-Panel. Visiting. Houston, TX, US.
32. 2015. Sentinel Nodes for Melanoma. Invited. San Diego, CA, US.
33. 2014. What's New in Surgery and Regional Therapies for Melanoma. Invited. Tampa, FL, US.
34. 2014. When is Surgery Indicated in Stage IV and Advanced Stage III Disease?. Invited. Atlanta, GA, US.
35. 2014. Surgery for Advanced Stage III and Stage IV Melanoma. Invited. Atlanta, GA, US.
36. 2014. Sentinel Node Evaluation - Part II. Invited. San Diego, CA, US.
37. 2014. Sentinel Node Evaluation - Part I. Invited. San Diego, CA, US.
38. 2013. Sentinel Node Evaluation Part II. Invited. San Diego, CA, US.
39. 2013. Melanoma - Case Presentations. Invited. San Diego, CA, US.
40. 2013. Sentinel Node Evaluation Part I. Invited. San Diego, CA, US.
41. 2012. Current Trends in the Treatment of Malignant Melanoma. Invited. Salt Lake, UT, US.
42. 2012. Current Trends in the Treatment of Malignant Melanoma. Visiting. Salt Lake City, UT, US.
43. 2012. Melanoma: Case Presentations. Invited. San Diego, CA, US.
44. 2012. Sentinel Node Evaluation Part II. Invited. San Diego, CA, US.
45. 2012. Sentinel Node Evaluation Part I. Invited. San Diego, CA, US.
46. 2011. Melanoma Case Presentations - Part II. Invited. San Diego, CA, US.
47. 2011. Sentinel Node Evaluation - Part II. Invited. San Diego, CA, US.
48. 2011. Melanoma Case Presentations - Part I. Invited. San Diego, CA, US.
49. 2011. Sentinel Node Evaluation - Part I. Invited. San Deigo, CA, US.
50. 2010. Upcoming Modifications in Melanoma Staging System 2010. Invited. Las Vegas, NV, US.
51. 2010. Panel Discussion: Data on One Versus Two Procedures for SLN and Completion Lymphadenectomy. Invited. Las Vegas, NV, US.
52. 2010. Sentinel Node Evaluation. Invited. LaJolla, CA, US.
53. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Colorado Springs, CO, US.
54. 2009. A Case-Based Approach to the Treatment of Melanoma. Visiting. San Antonio, TX, US.
55. 2009. A Case-Based Approach to the Treatment of Melanoma. Visiting. El Paso, TX, US.
56. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Houston, TX, US.
57. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Greenwood Village, CO, US.
58. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Denver, CO, US.
59. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Houston, TX, US.
60. 2009. Regional Chemotherapeutic Approaches to Recurrent Extremity Melanoma and Other Solid Tumors. Visiting. Allentown, PA, US.
61. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Danville, PA, US.
62. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Williamsport, PA, US.
63. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Cleveland, OH, US.
64. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Cleveland, OH, US.
65. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and Challenges. Visiting. Louisville, KY, US.
66. 2009. A Case-Based Approach to the Treatment of Melanoma. Visiting. Houston, TX, US.
67. 2009. I have melanoma, where do I go from here?. Visiting. Houston, TX, US.
68. 2009. HER-2 Positive Breast Cancer: Diagnostic Tools and Challenges. Visiting. Cherry Hill, NJ, US.
69. 2009. Utilization of OncotypeDX Risk Score in Node Negative and Node Positive Early Stage Breast Cancer Patients. Visiting. Houston, TX, US.
70. 2009. HER-2 Positive Breast Cancer: Diagnostic Tools and Challenges. Visiting. Kansas City, MO, US.
71. 2009. HER-2 Positive Breast Cancer: Diagnostic tools and challenges. Invited. Flint, MI, US.
72. 2009. HER-2 Positive Breast Cancer: Diagnostic Tools and Challenges. Visiting. Flint, MI, US.
73. 2009. Melanoma Update. Visiting. Chicago, IL, US.
74. 2009. Surgical management of stage I & II melanoma: An evidence-based discussion. Visiting. Houston, TX, US.
75. 2009. HER-2 Positive Breast Cancer: Diagnostic Tools and Challenges. Visiting. Anchorage, AK, US.
76. 2009. Sentinel Node Evaluation. Invited. San Diego, CA, US.
77. 2008. HER2-Positive Breast Cancer: Diagnostic Tools and Challenges. Invited. McAllen, TX, US.
78. 2008. Sentinel Node Evaluation, Pros and Cons and Impact of Treatment Decisions. Invited. Columbus, OH, US.
79. 2008. Sentinel Node Evaluation. Invited. San Diego, CA, US.
80. 2007. Melanoma Staging and the Role of Sentinel Lymph Node Biopsy: Update on Regional Nodal Evaluation for Melanoma-Results of MSLT-1 and Future Studies. Invited. Cleveland, OH, US.
81. 2007. Advances In Treating the Melanoma Patient. Invited. Boston, MA, US.
82. 2007. Surgical Advances in the Treatment of the Melanoma Patient. Invited. Boston, MA, US.
83. 2007. Melanoma Surgery. Visiting. Louisville, KY, US.
84. 2007. The Ever-Evolving Role of Lymphatic Mapping and Sentinel Node Biopsy in Treating the Melanoma Patient. Visiting. Louisville, KY, US.
85. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Oklahoma City, OK, US.
86. 2007. Stage II and III Melanoma and Metastatic Melanoma. Invited. New York, NY, US.
87. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Fort Worth, TX, US.
88. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Metairie, LA, US.
89. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Miami, FL, US.
90. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Houston, TX, US.
91. 2007. Herception (Trastuzumab) for the Adjuvent Treatment of HER2-Positive Node-Positive Breast Cancer. Invited. Galveston, TX, US.
92. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Shreveport, LA, US.
93. 2007. HER2-Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. Sarasota, FL, US.
94. 2007. Sentinel Lymph Node Controversies in the Management of Melanoma Patients. Visiting. Jacksonville, FL, US.
95. 2007. Sentinel Lymph Node Controversies in the Management of Melanoma Patients. Invited. Jacksonville, FL, US.
96. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Jacksonville, FL, US.
97. 2007. HER2-Positive Breast Cancer: Diagnostic Tools and Challenges. Invited. Fort Myers, FL, US.
98. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Fort Worth, TX, US.
99. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Greenwood Village, CO, US.
100. 2007. HER2-Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. Chicago, IL, US.
101. 2007. Surgical Controversies in Treating Melanoma. Invited. San Francisco, CA, US.
102. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Metairie, LA, US.
103. 2007. Sentinel Lymph Node Biopsy: Controversies in Melanoma. Invited. Orange, CA, US.
104. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Santa Ana, CA, US.
105. 2007. Surgical Advances in Treating Melanoma. Visiting. Chicago, IL, US.
106. 2007. Updates in the Treatment of Malignant Melanoma. Invited. Oakbrook, IL, US.
107. 2007. Her2-Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. Abita Springs, LA, US.
108. 2007. HER2-Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. Houston, TX, US.
109. 2007. Current Status of Sentinel Node Evaluation in Melanoma & Breast Cancer. Visiting. La Jolla, CA, US.
110. 2007. Current Treatment Options in the Management of the Melanoma Patient. Invited. Boston, MA, US.
111. 2007. HER-2 Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. Houston, TX, US.
112. 2007. Sentinel Lymph Node Biopsy in the Treating of Malignant Melanoma. Invited. Atlanta, GA, US.
113. 2007. Surgical Treatment of Melanoma. Invited. Houston, TX, US.
114. 2007. Impact of AJCC Staging. Invited. Chapel Hill, NC, US.
115. 2006. Updates in the Treatment of Malignant Melanoma. Invited. Boston, MA, US.
116. 2006. HER2-Targeted Therapy in the Treatment of Metastatic Breast Cancer. Invited. New Orleans, LA, US.
117. 2006. Updates in the Treatment of Malignant Melanoma. Invited. Lafayette, LA, US.
118. 2006. Is Early Lymph Node Analysis Important?. Visiting. San Diego, CA, US.
119. 2006. Melanoma in the New Millennium. Invited. Houston, TX, US.
120. 2006. Updates in the Treatment of Malignant Melanoma. Invited. Baton Rouge, LA, US.
121. 2006. Historical, Prospective, and Future Systemic Therapy for Melanoma. Visiting. Houston, TX, US.
122. 2006. The Ever-Evolving Role of Lymphatic Mapping and Sentinel Node Biopsy in Treating the Melanoma and Breast Cancer Patient. Visiting. Hartford, CT, US.
123. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Long Beach, CA, US.
124. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Beverly Hills, CA, US.
125. 2005. Systemic Adjuvant Therapy for Melanoma: Update on Interferon and Vaccines. Visiting. Houston, TX, US.
126. 2005. Skin Cancer Prevention and Early Detection Techniques for the Spa Professional. Invited. Orlando, FL, US.
127. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Las Vegas, NV, US.
128. 2005. Surgery for Stage IV Melanoma. Visiting. Houston, TX, US.
129. 2005. Management of Melanoma Extremity In-transit Disease. Visiting. Houston, TX, US.
130. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Buffalo, NY, US.
131. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Rochester, NY, US.
132. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Lynchburg, VA, US.
133. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Roanoke, VA, US.
134. 2005. Updates in the Treatment of Malignant Melanoma. Invited. Buffalo, NY, US.
135. 2005. Stage IV Melanoma: Surgical and End of Life Issues. Invited. Houston, TX, US.
136. 2005. Updates in the Treatment of Malignant Melanoma. Invited. New Orleans, LA, US.
137. 2005. Lymphatic Mapping and Sentinel Node Biopsy in Treating Breast Cancer and Melanoma. Visiting. La Jolla, CA, US.
138. 2005. Surgical Advances in the Treatment of Malignant Melanoma. Visiting. Dallas, TX, US.
139. 2004. Melanoma in the New Millennium. Invited. Chicago, IL, US.
140. 2002. Lymphatic Mapping for Breast Cancer. Visiting. Houston, TX, US.
141. 2002. Lymphatic Mapping and Sentinel Node Biopsy in the Treatment of Malignant Melanoma. Visiting. Houston, TX, US.
142. 2002. Sentinel Node Biopsy for Breast Cancer. Visiting. Houston, TX, US.
143. 2002. Malignant Melanoma. Visiting. Houston, TX, US.
144. 2002. High and Low Dose Interferon for Malignant Melanoma. Visiting. Houston, TX, US.
145. 2002. High and Low Dose Interferon for Malignant Melanoma. Visiting. Houston, TX, US.
146. 2002. Current Trends in the Treatment of Malignant Melanoma. Invited. Vancouver, CA.
147. 2002. Sentinel Node Biopsy for Melanoma. Invited, SC, US.
148. 2002. Current Treatments in the Management of Malignant Melanoma. Visiting. Houston, TX, US.
149. 2002. Sentinel Node Biopsy for Melanoma – Current Status. Visiting. London, US.
150. 2002. Isolated Limb Perfusion: The MD Anderson Experience. Visiting. London, US.
151. 2001. Malignant Melanoma. Visiting. Houston, TX, US.
152. 2001. Current Status of Sentinel Lymph Node Biopsy for Malignant Melanoma. Visiting. Houston, TX, US.
153. 2001. Semi-Annual Meeting. Invited. Chicago, IL, US.
154. 2001. Sarcoma. Visiting. Houston, TX, US.
155. 2001. Current Status of Sentinel Lymph Node Biopsy. Visiting. Houston, TX, US.
156. 2001. Merkel Cell Cancer. Visiting. Houston, TX, US.
157. 2001. Pigmented Lesions [Proctor/Presenter]. Visiting. Houston, TX, US.
158. 2001. Malignant Melanoma. Visiting. Houston, TX, US.
159. 2001. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
160. 2001. Sentinel Node Biopsy – A Surgical Perspective. Visiting. Houston, TX, US.
161. 2001. Sentinel Node Biopsy Techniques. Visiting. Houston, TX, US.
162. 2001. DCIS for Breast Cancer. Visiting. Houston, TX, US.
163. 2001. Lymphatic Mapping and Sentinel Node Biopsy in Malignant Melanoma. Visiting. Houston, TX, US.
164. 2001. 2nd Melanoma Consensus Group Meeting. Invited. Zurich, CH.
165. 2001. Melanoma Faculty Surgery Group Meeting. Invited. Houston, TX, US.
166. 2001. PEG-Intron Melanoma Advisory Board Meeting. Invited. Denver, CO, US.
167. 2001. American College of Surgeons Oncology Group – Semiannual Meeting. Invited. Chicago, IL, US.
168. 2001. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
169. 2001. NSABP Review. Visiting. Houston, TX, US.
170. 2001. Sentinel Node Biopsy as a Treatment for Melanoma. Invited. Tulsa, OK, US.
171. 2000. Advances in the Management of Malignant Melanoma. Visiting. Worcester, MA, US.
172. 2000. Panel Discussion. Invited. Chicago, IL, US.
173. 2000. Advances in Melanoma Management. Invited. Chicago, IL, US.
174. 2000. Sentinel Node Mapping for Breast Cancer. Invited. Oxford, MS, US.
175. 2000. Sentinel Node Biopsy for Malignant Melanoma. Visiting. Baton Rouge, LA, US.
176. 2000. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer. Visiting. Covington, LA, US.
177. 2000. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
178. 2000. Surgical Advances in the Treatment of Malignant Melanoma. Visiting. Little Rock, AK, US.
179. 2000. Nodal Micrometastases: Prognostic Implications in Melanoma and Breast Cancer. Visiting. Houston, TX, US.
180. 2000. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
181. 2000. Lymphatic Mapping for Malignant Melanoma. Visiting. Houston, TX, US.
182. 2000. New Perspectives in Melanoma. Visiting. Dallas, TX, US.
183. 2000. Skin-Sparing Mastectomy. Invited. Des Moines, IA, US.
184. 2000. Recent Developments in the Management of Melanoma. Invited. Des Moines, IA, US.
185. 2000. Prognostic Factors in Melanoma. Invited. San Diego, CA, US.
186. 2000. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
187. 1999. Medical and Surgical Management of the Melanoma Patient. Visiting. Portland, ME, US.
188. 1999. Surgical Advances in the Treatment of Melanoma. Visiting. Boston, MA, US.
189. 1999. Medical and Surgical Management of the Melanoma Patient. Visiting. Dartmouth, NH, US.
190. 1999. Update on Melanoma Staging. Visiting. New York, NY, US.
191. 1999. Surgical Advances in the Treatment of the Melanoma Patient. Visiting. Portland, ME, US.
192. 1999. Surgical Advances in the Treatment of the Melanoma Patient. Visiting. Dartmouth, NH, US.
193. 1999. Nodal Micrometastases: Prognostic Implications in Melanoma and Breast Cancer. Invited. Milan, IT.
194. 1999. Overview of Sentinel Node Biopsy in the Management of Breast Cancer and Malignant Melanoma. Invited. Newport Beach, CA, US.
195. 1999. Lymphatic Mapping and Sentinel Node Biopsy for Malignant Melanoma. Visiting. Houston, TX, US.
196. 1999. Melanoma/Pigmented Lesions. Visiting. Houston, TX, US.
197. 1999. Lymphatic Mapping and Sentinel Node Biopsy in the Management and Treatment of Breast Cancer. Invited. Denver, CO, US.
198. 1999. The Role for Lymphatic Mapping and Sentinel Node Biopsy in the Management of Melanoma and Breast Cancer. Invited. Denver, CO, US.
199. 1999. Breast Cancer and Melanoma: Sentinel Node Biopsy. Invited. Denver, CO, US.
200. 1999. Lymphatic Mapping and Sentinel Node Biopsy in the Treatment of Malignant Melanoma and Breast Cancer. Invited. Lake Charles, LA, US.
201. 1999. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
202. 1999. Lymphatic Mapping for Breast Cancer – An Update. Invited. Houston, TX, US.
203. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer. Visiting. San Diego, CA, US.
204. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer. Visiting. Sydney, AU.
205. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer – The MD Anderson Experiences. Visiting. Brisbane, AU.
206. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer- The MD Anderson Experience. Visiting. Perth, AU.
207. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer. Visiting. Melbourne, AU.
208. 1999. Surgical Advances in the Treatment of Malignant Melanoma and Breast Cancer. Visiting. Adelaide, AU.
209. 1999. Sentinel Node Evaluation Review Indications/Techniques and Methods. Invited. Orange, CA, US.
210. 1999. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
211. 1999. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TX, US.
212. 1998. Modern Management of Malignant Melanoma. Invited. Amarillo, TX, US.
213. 1998. Adjuvant Approaches to the High-Risk Melanoma Patient: Immunotherapy and Vaccines. Invited. Amarillo, TX, US.
214. 1998. Lymphatic Mapping and Sentinel Node Biopsy for Malignant Melanoma. Invited. Alexandria, VA, US.
215. 1998. Prevention of Skin Cancer. Invited. Houston, TX, US.
216. 1998. Sentinel Node Biopsies for Breast Cancer. Visiting. Beaumont, TX, US.
217. 1998. Sentinel Node Evaluation in Melanoma. Invited. La Jolla, CA, US.
218. 1998. Surgical Approaches for Treating Malignant Melanoma. Visiting. Houston, TX, US.
219. 1998. Diagnosis and Investigation of Sarcoma. Visiting. Buckinghamshire, US.
220. 1998. Melanoma: Surgical Advances. Visiting. Buckinghamshire, US.
221. 1998. Sentinel Lymph Node Biopsy. Visiting. Buckinghamshire, US.
222. 1998. Sentinel Lymph Node Mapping in the Management of Early Stage melanoma and Breast Cancer. Invited. Houston, TX, US.
223. 1998. NSABP Review. Visiting. Houston, TX, US.
224. 1998. Sentinel Node Mapping in Breast Cancer. Invited. Sao Paulo, BR.
225. 1998. Lymphatic Mapping for Malignant Melanoma. Invited. Sao Paulo, BR.
226. 1998. Sentinel Lymph Node Biopsy and the MD Anderson Experience. Invited. Memphis, TN, US.
227. 1998. Sentinel Node Status for Breast Cancer. Invited. Houston, TX, US.
228. 1998. Margins of Excision for Primary Melanoma. Visiting. Inglewood, CA, US.
229. 1998. Limb Perfusion for Intransit Metastases. Visiting. Loma Linda, CA, US.
230. 1998. Lymphatic Mapping and Sentinel Node Biopsy for Melanoma. Visiting. Santa Monica, CA, US.
231. 1998. Isolated Limb Perfusion for Intransit Metastases. Invited. Palm Springs, CA, US.
232. 1998. Lymphatic Mapping and Sentinel Node Biopsy. Visiting. Whittier, CA, US.
233. 1998. Limb Perfusion for Intransit Metastases. Visiting. Loma Linda, CA, US.
234. 1998. Surgical Approach to Treating the Melanoma Patient. Visiting. Houston, TX, US.
235. 1998. Surgical Management of Malignant Melanoma Including Lymphoscintigraphy. Visiting. Houston, TX, US.
236. 1998. Surgical Management of Breast Cancer. Visiting. Houston, TX, US.
237. 1998. Regional Treatment Advances for Melanoma. Visiting. Houston, TX, US.
238. 1998. Adjuvant Treatment of Metastatic Melanoma. Invited. Newport Beach, CA, US.
239. 1998. The Surgical Management of Melanoma. Invited. Newport Beach, CA, US.
240. 1998. Surgical Management of Breast Cancer. Invited. Houston, TX, US.
241. 1998. Surgical Management of Malignant Melanoma. Invited. Fort Lauderdale, FL, US.
242. 1998. Surgical Management of Malignant Melanoma & Breast Cancer. Invited. Fort Lauderdale, FL, US.
243. 1998. Lymphatic Mapping and Sentinel Node Biopsy: Surgical Techniques in the Management of Malignant Melanoma. Invited. Laguna Niguel, CA, US.
244. 1998. Lymphatic Mapping and Sentinel Node Biopsy: Surgical Techniques. Invited. Houston, TX, US.
245. 1998. Surgical Management of Malignant Melanoma. Visiting. Houston, TX, US.
246. 1998. Surgical Management of Breast Cancer. Visiting. Houston, TX, US.
247. 1998. Melanoma Staging. Invited. Coconut Grove, FL, US.
248. 1998. Surgical Management in the Treatment of Malignant Melanoma & Breast Cancer. Visiting. Ann Arbor, MI, US.
249. 1997. Surgical Advances in the Treatment of Malignant Melanoma & Breast Cancer. Visiting. Hamilton, CA.
250. 1997. Surgical Techniques for the Treatment of Malignant Melanoma and Breast Cancer. Invited. Cleveland, OH, US.
251. 1997. Surgical Management of Breast Cancer. Visiting. Houston, TX, US.
252. 1997. Surgical Management in the Treatment of Breast Cancer. Visiting. Milwaukee, WI, US.
253. 1997. Melanoma and the Use of the Neoprobe. Invited. Pensacola, FL, US.
254. 1997. Surgical Advances in the Management of Malignant Melanoma and Breast Cancer. Invited. Evanston, IL, US.
255. 1997. Melanoma – Role of the Sentinel Node. Invited. Akron, OH, US.
256. 1997. Contemporary Surgical Approaches to the Management of Melanoma. Visiting. Houston, TX, US.
257. 1997. New Modalities in the Surgery for Melanoma. Invited. Mexico City, MX.
258. 1997. Sentinel Node Biopsy in Melanoma and Breast Cancer. Invited. Aurora, IL, US.
259. 1997. Sentinel Lymph Node Assessment in Breast Cancer. Invited. Rockville, MD, US.
260. 1997. Sentinel Lymph Node Assessment in Melanoma. Invited. Rockville, MD, US.
261. 1997. Lymphatic Mapping for Breast and Melanoma: New Diagnostic Procedures and Treatment. Invited. Houston, TX, US.
262. 1997. Sentinel Node Biopsy for Early Stage Melanoma. Visiting. Houston, TX, US.
263. 1997. Surgical Management of Breast Cancer. Invited. Houston, TX, US.
264. 1997. Breast Cancer. Visiting. Houston, TX, US.
265. 1997. Melanoma: Update. Invited. Houston, TX, US.
266. 1997. Complex Management Issues in the Melanoma Patient. Invited. Honolulu, HI, US.
267. 1996. Surgical Approach to Treating the Melanoma Patient. Visiting. Houston, TX, US.
268. 1996. Lymphatic Mapping and Sentinel Node Biopsy in the Management of Malignant Melanoma. Invited. Houston, TX, US.
269. 1996. Lymphatic Mapping and Sentinel Node Biopsy in the Management of Malignant Melanoma. Invited. Denver, CO, US.
270. 1996. The Sentinel Lymph Node Mapping Techniques for the Treatment of Malignant Melanoma. Invited. Philadelphia, PA, US.
271. 1996. Surgical Management of Melanoma. Visiting. Houston, TX, US.
272. 1996. Surgical Management of Breast Cancer. Visiting. Houston, TX, US.
273. 1996. Surgical Approach to Treating the Melanoma Patients. Invited. Houston, TX, US.
274. 1996. Surgical Management of Malignant Melanoma. Visiting. Newport Beach, CA, US.
275. 1996. Lymphadenectomy. Invited. San Francisco, CA, US.
276. 1996. Lymphatic Mapping. Invited. San Francisco, CA, US.
277. 1996. Surgical Approach to Treating the Melanoma Patient. Invited. Houston, TX, US.
278. 1996. Early Detection Diagnosis and the Role of Sentinel Node Mapping. Invited. Pittsburgh, PA, US.
279. 1996. Surgical Management of Breast Cancer. Invited. Houston, TX, US.
280. 1996. Surgical Management in Malignant Melanoma Including Lymphoscintigraphy. Invited. Houston, TX, US.
281. 1996. Cadaveric Study. Invited. Cincinnati, OH, US.
282. 1996. Malignant Melanoma: New Approaches with Local and Systemic Therapies. Invited. Lubbock, TX, US.
283. 1996. Melanoma. Visiting. Houston, TX, US.
284. 1996. Surgical Management of Breast Cancer. Visiting. Houston, TX, US.
285. 1996. Surgical Management in Malignant Melanoma Including Lymphoscintigraphy. Visiting. Houston, TX, US.
286. 1996. Lymphatic Mapping and Sentinel Node Biopsy. Invited. Tampa, FL, US.
287. 1996. Lymphatic Mapping and Sentinel Node Biopsy. Invited. Worthington, OH, US.
288. 1996. Ethicon Endoscopic-Surgery. Visiting. Cincinnati, OH, US.
289. 1996. The Surgical Management of Melanoma. Invited. Rancho Santo Fe, CA, US.
290. 1996. New Advances in the Treatment of Malignant Melanoma. Invited. Baton Rouge, LA, US.
291. 1996. New Advances in the Treatment of Malignant Melanoma. Invited. New Orleans, LA, US.
292. 1996. New Advances in the Treatment of Malignant Melanoma. Invited. Thibodeaux, LA, US.
293. 1996. Regional Lymphatic Mapping. Visiting. Houston, TX, US.
294. 1996. Adjuvant Therapy for High Risk Melanoma. Invited. Houston, TX, US.
295. 1996. Lymphatic Metastasis Melanoma. Visiting. Houston, TX, US.
296. 1995. MELANOMA. Invited. Houston, TX, US.
297. 1995. Lymphatic Mapping in the Management of Early Stage Melanoma. Visiting. Vancouver, CA.
298. 1995. Breast Cancer Awareness and Early Detection. Invited. Houston, TX, US.
299. 1995. Early Detection of Melanoma. Visiting. Chicago, IL, US.
300. 1995. Malignant Melanoma. Visiting. Victoria, TX, US.
301. 1995. The Surgical Management of Melanoma. Invited. Durham, NC, US.
302. 1995. Surgical Options Rehab and Recovery. Invited. Houston, TX, US.
303. 1995. Southwest Advisory Board on Intron-A in Melanoma. Invited. Marina del Rey, CA, US.
304. 1995. Multidisciplinary Approach to Treating the Melanoma Patient. Invited. Houston, TX, US.
305. 1994. Surgical Management of Early Breast Cancer. Invited. Irving, TX, US.
306. 1994. Current Surgical Management of Melanoma. Visiting. Orlando, FL, US.
307. 1994. Axillary Node Dissection for Breast Cancer: A Contemporary Controversy. Visiting. Orlando, FL, US.
308. 1994. Melanoma: Primary Excision and Regional Node Dissection. Invited. Houston, TX, US.
309. 1993. Melanoma Case Presentations. Invited. Houston, TX, US.
310. 1993. Management of Stage I and II Breast Cancer. Visiting. Houston, TX, US.
311. 1993. Management of Soft Tissue Sarcomas. Visiting. Tampa, FL, US.
312. 1993. Lymphoscintigraphy and Melanoma. Invited. Houston, TX, US.
313. 1993. WHO Melanoma Trials. Invited. Houston, TX, US.
314. 1993. Management of Stage I and II Breast Cancer. Invited. Houston, TX, US.
315. 1993. Pathophysiology Staging and Surgical Management of Melanoma. Invited. Houston, TX, US.
316. 1992. Innovations in Melanoma Therapy. Invited. Mexico City, MX.
317. 1992. State of the Art Breast Cancer Therapy. Invited. Mexico City, MX.
318. 1992. Management of Stage I and II Breast Cancer. Visiting. Houston, TX, US.
319. 1992. A Review of the National Surgical Adjuvant Breast Project. Invited. Houston, TX, US.
320. 1992. Management of Melanoma and Sarcoma. Invited. Houston, TX, US.
321. 1992. Surgical Management of Melanoma. Invited. Houston, TX, US.
322. 1992. Recent Advances in the Treatment of Melanoma. Invited. Abington, PA, US.
323. 1992. Surgical Approaches for Cutaneous Melanoma. Invited. Mexico City, MX.
324. 1992. Management of Melanoma and Sarcoma. Invited. Houston, TX, US.
325. 1992. MTP-PE Update. Invited. Houston, TX, US.
326. 1992. Intraoperative Lymphatic Mapping in Melanoma. Invited. Houston, TX, US.
327. 1992. Management of Melanoma and Sarcoma. Invited. Houston, TX, US.
328. 1992. Management of the Breast Lump. Invited. Houston, TX, US.
329. 1991. Surgical Management of Breast Cancer. Invited. Houston, TX, US.
330. 1991. Surgical Management of Breast Cancer. Invited. Durango, CO, US.
331. 1991. Melanoma: Diagnosis and Treatment. Invited. Houston, TX, US.
332. 1991. Prophylactic Mastectomy. Invited. Houston, TX, US.
333. 1991. Surgical Therapy for Melanoma. Invited. Houston, TX, US.
334. 1991. Diagnosis and Treatment of Breast Cancer. Invited. Clear Lake, TX, US.
335. 1991. Management of Melanoma and Sarcoma. Invited. Houston, TX, US.
336. 1991. Breast Cancer. Invited. Joplin, MI, US.
337. 1991. Recent Advances in Breast Cancer. Invited. Lufkin, TX, US.
338. 1990. Management of Melanoma and Sarcoma. Invited. Houston, TX, US.
339. 1990. Immunoradiodetection of Recurrent Colorectal-Rectal Cancer. Invited. Houston, TX, US.
340. 1989. Surgical Management of Colorectal and Anal Cancer. Invited. Houston, TX, US.
341. 1989. The Basics of Immunotherapy. Invited. Houston, TX, US.
342. 1989. Surgical Management of Stage I and II Breast Cancer. Invited. Houston, TX, US.
343. 1989. Patterns of Failure in Anorectal Melanoma a Guide to Surgical Therapy. Invited. Houston, TX, US.